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The innate immune system consists of a number of genetically encoded receptors
that detect the products of viral replication and initiate signaling cascades leading to
activation of the antiviral response. During the course of infection, many viruses produce
dsRNA that can be recognized by two major arms of the innate immune system: the tolllike receptors (TLR) and the Rig-I-like receptors (RLR). Among the TLRs, TLR3 binds
dsRNA within the endosomal compartment and initiates signaling through its
downstream adapter TRIF. Melanoma differentiation-induced gene 5 (MDA5) is a
member of the RLR family that recognizes dsRNA within the cytosolic compartment and
signals through the adaptor IPS-1. Although TLR3 and MDA5 initially employ distinct
downstream adaptors, both are known to induce the production of cytokines and cell
surface molecules involved in the antiviral response, which raises the question of whether
they are redundant or functionally distinct. Using mice that are genetically deficient for
MDA5, TLR3, or both MDA5 and TLR3 (double knockout, DKO), we have
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demonstrated that these receptors have unique functions necessary for controlling viral
infection.
Using two models of viral infection, murine norovirus (MNV) and
encephalomyocarditis virus (EMCV), we demonstrate that both MDA5 and TLR3 limit
viral replication. Neither MDA5-/- nor TLR3-/- animals controlled MNV and EMCV
infection as well as wild type (WT) controls, but DKO mice were more susceptible to
infection than either single knockout. Furthermore, we find that MDA5 and TLR3 play
distinct roles in activating the natural killer (NK) cell response to the dsRNA analogue
poly I:C (pIC). We demonstrate that the discrete functions of MDA5 and TLR3 are
dependent on their expression in different cell types as well as their unique capacities to
control production of cytokines. In addition, we show that the individual contribution of
each sensor is necessary at distinct phases of the innate immune response, with TLR3
acting initially and MDA5 acting at later time points. These results illustrate how
cooperation between the TLR and RLR pathways is necessary for the development of a
complete antiviral response.
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Chapter 1
INTRODUCTION

1

Abstract
Viral pathogens have been discovered in all species from single-cell bacteria to
the largest mammals. In order to protect themselves from the pathogenic effects of these
invaders, organisms have been required to develop mechanisms to detect and limit viral
infection. In mammals this requirement has evolved the adaptive immune system, which
is able to generate highly specific antibodies and T cells that recognize specific viral
proteins and peptides that either block infection or target infected cells for destruction.
Initiation of the adaptive immune response, however, is a slow process that requires days
to weeks for maximum effect. To provide protection during the initial hours and days of
infection mammals have maintained a system of pattern-recognition receptors (PRR) first
seen in lower organisms that recognize broad motifs common to viral pathogens and thus
serve as the initial sensors of viral infection. These sensors initiate the adaptive antiviral
response as well as trigger the innate immune pathways that protect the host during early
infection while the more specific adaptive response develops. This chapter will provide
an introduction to the role of small non-enveloped RNA viruses in human disease,
describe the innate immune response to infection with these viruses, and detail the
molecular pathways responsible for the detection of viral infection.
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Small RNA viruses in disease
Members of the picornaviruses and caliciviruses families consist of small, nonenveloped viruses containing a positive-sense RNA genome1. Although small, viruses
from these families are responsible for a surprisingly large number and range of human
diseases as shown in Table 1.1. These viruses are typically transmitted in a fecal-oral
manner and replicate in the alimentary tract, although several can also be spread through
respiratory transmission. Several picornavirus family members can also cause systemic
as well as gastrointestinal illness in humans and animals, such as encephalitits,
myocarditis, hepatitis, and have been linked to type 1 diabetes1. Caliciviruses have been
shown to be the most common cause of nonbacterial epidemic gastroenteritis worldwide26

and have mostly been detected in the gastrointestinal tract.
Picornavirus and calicivirus genomes both contain a unique 5’ covalent linkage to

a protein called VPg, which has been linked to a role in viral RNA synthesis 7-9.
Picornaviruses contain a single long open reading frame (ORF) and viral proteins are
obtained from processing of the polyprotein1. Caliciviruses have at least two ORFs and
the exact number depends on the genus10,11. Picornaviruses gain entry to cells by
attaching to host cell membrane receptors. A variety of receptors are employed by
different viruses, including CD155 (poliovirus), VCAM-1 (EMCV), DAF (coxsackie A
viruses), and Coxsackievirus-Adenovirus Receptor (coxsackie B viruses)1. The cellular
receptors for caliciviruses are currently unknown, but human volunteer studies suggest
that replication occurs in the upper intestinal tract 12,13. The use of different receptors for
entry by picornavirus and calicivirus family members likely results in the distinct viral
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tropism and ability to cause different diseases, some of which will be discussed in more
detail below.

Myocarditits
Myocarditis is a cardiac disease in which the myocardium becomes inflamed and
injured in the absence of an ischemic event. Most cases of myocarditis have been linked
to an infectious origin, with viruses being the most common cause in North America14.
At least 20 viruses have been linked to the disease15, but in humans, coxsackie viruses
seem to be the dominant pathogen16,17. The incidence of myocarditis is unclear because
most cases are likely to be asymptomatic and even in cases in which endometrial biopsy
is available there is disagreement among pathologists about the exact diagnostic criteria18.
However, most studies have shown that a majority of cases occur in children and young
adults. The disease consists of three phases: acute, subacute, and chronic. In the acute
phase there is active viral replication in the myocardium, the initial production of
inflammatory cytokines, and a limited macrophage and NK cell infiltrate. The subacute
phase consists of viral release, a large lymphocytic infiltrate, and a more massive
cytokine response leading to viral clearance. The chronic phase typically consists of very
low levels or the absence of viral particles but also fibrosis and remodeling of the
myocardium leading to dilated cardiomyopathy and congestive heart failure14.
The availability of several mouse models of myocarditis has begun to reveal some
of the mechanisms of disease progression. A.BY/SnJ and SWR/J strains of mice have
been shown to be susceptible to a more chronic form of myocarditis while C57BL/6 and
DBA1/J strains have a more acute, rapidly clearing form of the disease when infected
4

with either coxsackie B virus (CVB) or EMCV19-21. Using these models, there are
currently three main theories concerning the mechanism of myocardial damage that
occurs in viral myocarditis14. 1. Excessive immune-mediated destruction of virally
infected and surrounding myocardium by immune infiltrates. 2. Autoimmune destruction
of myocardium by self-reactive cells and antibodies triggered by release of cardiac
proteins or viral mimicry. 3. Direct myocardial injury by virus. There is evidence of all
three forms of myocardial damage in different models22-24. Based on these somewhat
contradictory results, it is currently unclear whether the immune system is protective or
pathogenic in viral myocarditis. Recent experiments have demonstrated that antiinflammatory cytokine IL-10 and in a human clinical trial, anti-viral cytokine IFNβ have
protective effects in myocarditis and result in improved cardiac function25,26. However,
in other clinical trials, general immunosuppression with prednisone had no significant
effect on the outcome of myocarditis27. These studies highlight the complexity of the
balance between the protective and harmful effects of the immune response to
myocarditis and the potential that myocarditis is not one disease but rather a collection of
diseases with differing etiologies.

Diabetes
Type 1 diabetes mellitus (T1DM) is caused by progressive destruction of the beta
(β) cells in the pancreatic islets leading to hypoinsulinemia and hyperglycemia.
Population based and familial studies as well as animal models have revealed that several
genetic factors contribute to the risk of developing the disease, however, the precise
mechanisms that lead to the initiation and development of T1DM remain unknown 28,29.
5

The high discordance rate (<50%) of T1DM in monozygotic twins as well the rapidly
increasing incidence rates in certain geographic locations strongly suggest that
environmental factors also contribute to the disease30,31. It has long been hypothesized
that viral infection may be related to T1DM32. Indeed, human studies have found virusspecific antibodies in the serum and viral antigen in the pancreatic islets of recent onset
T1DM patients33-35. There are several theories explaining how viral infection could lead
to T1DM including: (i) direct virus-mediated destruction of β-cells, (ii) molecular
mimicry of host proteins by viral antigens36, (iii) release of novel antigens from β-cells
upon viral infection leading to activation of auto-reactive cells37, (iv) the production of
inflammatory and immune cytokines that cause bystander activation38, and (v) production
of type I interferon (IFN) by infected cells leading to increased immune targeting of βcells39. Although a number of different viruses have been linked to T1DM, the most
common association in humans is with coxsackieviruses40-42.
A variety of animal models have also provided evidence that viruses can trigger
T1DM. Infection of the Biobreeding (DR-BB) rat with Kilham rat virus and susceptible
mouse strains with encephalomyocarditis virus (EMCV) lead to diabetes in those
normally resistant animals43,44. In addition, T1DM was induced in mice after infection
with a CVB4 strain isolated from a human patient with diabetic ketoacidosis40.
Conversely, there is also evidence that viruses can be protective and limit development of
T1DM in susceptible individuals. Indeed, this is proposed in the hygiene hypothesis45,
originally proposed for asthma, which attempts to explain the increasing incidence of
autoimmune diseases as a result of lower incidence of enterovirus infection. In support
of this theory, NOD mice, which develop an autoimmune T cell mediated T1DM similar
6

to human disease, are protected from diabetes development if infected with EMCV of
CVB before the initiation of disease46. Further studies have suggested that viruses which
replicate quickly cause T1DM, while slowly replicating viruses are protective for the
disease47. One potential explanation for this apparent paradox has been suggested by
histological studies from human pancreatic tissues. Studies from Dotta at al have shown
two distinct patterns of T1DM in human pancreatic islets35. Pattern A is the classic
autoimmune form consisting of a T cell infiltrate similar to the disease seen in the NOD
mouse. Pattern B samples do not have T cell infiltrates, instead displaying marked
increases in natural killer (NK) cells and macrophages within the islets. Pattern B
samples are also more likely to include viral antigen than pattern A. This suggests that
T1DM may consist of multiple disease processes in which virus play distinct, even
contradictory roles.

Gastroenteritis
In humans, viral gastroenteritis results in vomiting, diarrhea, fever, malaise, and
abdominal pain within 24-48 hours after infection. These symptoms usually clear within
48-72 hours, but virus can persist for 3-6 weeks post-infection48,49. Viral gastroenteritis
can occur in clusters in a variety of settings such as hospitals, nursing homes, day care
centers, and cruise ships. Advances in diagnostic techniques has revealed that 90% of
viral gastroenteritic outbreaks and up to 36% of sporadic gastroenteritis cases can be
attributed to Norwalk virus and other human noroviruses2-6. There is great genetic
diversity among both human and animal noroviruses. A recent comparison of norovirus
sequences from around the world has suggested that a new pandemic strain emerges
7

every 2-4 years, indicating the importance of understanding the pathogenesis of
infection50.
Until recently the inability to culture norovirus in vitro as well as the lack of an
animal model have limited investigation into its pathogenicity. The discovery and
subsequent culture of murine norovirus-1 (MNV-1) has thus led to advances in
understanding both the viral lifecycle as well as the host response to infection51,52. These
studies have demonstrated that mice defective in the innate immune response are more
susceptible to severe norovirus infection. Similarly, human studies have revealed
increased susceptibility to norovirus infection in the very young, elderly, and
immunocompromised individuals50. Recent reports have also suggested additional
disease susceptibility factors. Noroviruses have been shown to bind to histo-blood group
antigens of the ABO, Lewis, and secretor families, and strain-specific susceptibility to
infection is dependent on blood group antigen and secretor status53-56. However, the wide
diversity of norovirus strains suggests that individuals who are resistant to one strain,
may be susceptible to another.
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Innate Immune response to small RNA virus infection
During viral infection a variety of cellular responders are activated to contain and
clear the infection. Upon penetration of the epithelial barriers and infection within host
tissues viruses, their replication products, and infected cells are recognized by tissue
phagocytic cells such as macrophages, neutrophils and dendritic cells, which produce
inflammatory and antiviral cytokines that serve to activate the innate immune response.
These cytokines, which will be detailed in the following sections, activate NK cells and
other innate lymphocytes, induce phagocyte maturation, lead to production of acute phase
antiviral products from the liver, and upregulate cell intrinsic antiviral responses. All of
these effects constitute the innate antiviral response.

Cellular
NK cells
NK cells develop from the common lymphocyte progenitor, but unlike
lymphocytes of the adaptive immune system, do not undergo genetic recombination of
their antigen receptors genes. Instead NK cells employ a variety of invariant receptors
that recognize cell surface receptors that are differentially modulated on virally infected
cells57. NK cells express both activating and inhibitory receptors on their cell surface and
the two-receptor hypothesis describes how these opposing receptors control their
activation58. Activating receptors bind ligands that are induced upon cellular stress such
as viral infection or transformation and signal for NK cytotoxicity against cells
expressing the target ligand. Inhibitory receptors bind MHC class I molecules which
9

traditionally present peptides to CD8 T cells of the adaptive immune system and are
normally expressed on healthy cells. The presence of inhibitory receptors prevents NK
cytotoxicity against uninfected targets. However, during infection, many viruses
downregulate MHC class I surface expression in order to evade the adaptive immune
response. If this occurs, then NK cell inhibitory receptors do not engage their ligand
resulting in an activating response and cytotoxicity. In addition to their cell surface
receptors, NK cells are activated by type I IFN and inflammatory cytokines produced
during viral infection, which result in increased baseline NK cell activation and cytotoxic
ability59. NK cells have been demonstrated to be important for control of both CVB and
EMCV infection in the context of myocarditis and diabetes60,61.
Innate-like lymphocytes
Innate-like lymphocytes (ILL) are cells of the lymphocyte lineage, which, similar
to NK cells, function in the innate immune system. There are two main types of ILLs
involved in control of viral infection, intraepitheial γ:δ T cells and NK T cells. Among
γ:δ T cells, there are two subsets, one which rearranges antigen receptor genes similar to
α:β T cells known as lymphoid γ:δ T cells, and intraepithelial γ:δ T cells. Unlike other T
cell types, intraepithelial γ:δ T cells have antigen receptors of very limited diversity62.
These cells are typically located in the skin and mucosal surfaces and are thought to
recognize a poorly defined selection of pathogen and host derived ligands directly,
independent of presentation on MHC molecules63. NK T cells express an invariant T cell
antigen receptor α chain and a limited selection of T cell β chains64. With this unique
antigen receptor, NK T cells have been demonstrated to recognize lipid antigens
presented on CD1d molecules. These cells are located within lymphatic tissues and are
10

thought to play a role in rapid secretion of cytokines early during infection.
Intraepithelial γ:δ T cells have been demonstrated to play a role in CVB myocarditis65,
while NK T cells have been implicated in EMCV-induced diabetes in animal models66.
Phagocytes
Macrophages, dendritic cells, and neutrophils have all been implicated in the
innate response to picornavirus infection67-70. These cells are known to phagocytose
infected cells as well as function in the production of antiviral and inflammatory
cytokines. Phagocytosis of virally infected cells serves two functions. First,
phagocytosis by macrophages and neutrophils results in degradation of viral particles by
lysosomal enzymes as well as reactive oxygen and nitrogen species leading to clearance
of infectious particles and control of infection. Second, phagocytosis and degradation
allows for recognition of viral products by PRR within macrophages and neutrophils.
These receptors, which will be described in detail in later sections, stimulate the
activation of phagocytic cells leading to increased antigen presentation, cytokine
production, and inflammatory mediators. Unlike macrophages and neutrophils, which
function at the site of infection, dendritic cells (DC) gather antigen from the site of
infection, then migrate to lymphatic tissues, where they function in the initiation of the
adaptive immune response. As part of this response, they produce large amounts of
cytokines, which besides informing the adaptive response, contribute to activation of the
innate response. In particular, DCs have been implicated in activation of the NK cell
response to viral infection71.

Cytokines
11

Viral infection induces the production of a variety of antiviral and inflammatory
cytokines from both infiltrating immune cells as well as infected cells themselves. Type I
IFN is acknowledged as a critical mediator of the antiviral response necessary to limit
viral infection, but inflammatory cytokines also recruit immune cells necessary for
control of infection.
Interferons
The initiation of IFN production is an essential step in the antiviral response.
There are three type of IFN produced during infection. Type I IFNs (IFN-α, IFN-β, IFNω, IFN-ε, and IFN-κ ) fight viruses both directly by inhibiting viral replication in cells
and indirectly by stimulating the innate and adaptive immune responses72. Type II IFN,
also known as IFNγ, has distinct functions compared to type I and type III IFNs. This
cytokine is produced by activated T cells, NK cells, and NK T cells and acts primarily on
macrophages leading to their activation and increased ability to kill intracellular
pathogens as well as stimulation of the adaptive immune response73. It has a much more
limited role on virally infected cells themselves. Recent studies have led to the
identification of type III IFNs (IFN-λ). These include three proteins, named IFN-l1, IFNl2, and IFN-l3, or interleukin-29 (IL-29) (l1) and IL-28A/B (l2/3). Although genetically
distinct from type I IFNs, type III IFNs have similar biological antiviral functions 74-76.
In contrast to type II IFN, type I and type III IFN can be produced by almost all nucleated
cells allowing for a variety of cells to initiate an antiviral response. A major difference
between type I and type III IFN, however, is that while the type I IFN receptor is
ubiquitously expressed, the type III IFN receptor has a more limited distribution,
suggesting some cellular specificity in the IFN response77,78.
12

IFN-α and IFN-β bind to the IFNα receptor (IFNAR) in an autocrine or paracrine
manner. Activation of this receptor leads to JAK/STAT signal transduction pathways
79,80

and the induction of a variety of IFN-induced genes. These genes increase the

cellular resistance to viral infection and sensitize virus-infected cells to apoptosis 81.
Interestingly, several viral sensors, which will be discussed in more detail later, are
among those genes induced by IFN. They in turn enable the production of IFN, creating
a positive feedback loop that enhances the response. In addition type I IFNs directly
activate DC and NK cells, and promote the survival and effector functions of T and B
cells, providing a link between the innate response to infection and the adaptive immune
response 82-85. The importance of type I IFN in control of viral infection is evidenced by
several mutations in mice and humans that affect this pathway and lead to severe
sensitivity to viral infection86-88, as well as the number of viruses that encode inhibitors of
IFN pathway components89.
Although type I IFN is critical for the control of virus infection, it has also been
linked to a variety of autoimmune diseases such as systemic lupus erythematosus,
rheumatoid arthritis, Sjögren’s syndrome, systemic sclerosis, and myositis72.
Autoimmune phenomena has also been seen in patients treated with IFN in the context of
viral infection90. It has recently been suggested that IFN is an initiating event in T1DM.
This is suggested by reports that IFN-induced gene upregulation is seen in islet samples
from newly diabetic patients35,91. In this context, IFN could function to upregulate
antigen presentation of β-cell antigens as well as activate immune cells leading to
autoimmune destruction of islets92 or perhaps lead to direct cytotoxic effects93.
Paradoxically, stimulation with IFN-inducing agents, such as dsRNA or virus, have a
13

protective effect in the NOD mouse and BB rat models of T1D46,94. Additionally,
production of IFNα and IFNβ was shown to be critical for prevention of CVB-induced
diabetes in a mouse model95. In this system IFN reduced the permissiveness of β-cells to
infection and limited NK-mediated death of these cells. These disparate results illustrate
that although IFN is necessary for control of viral infection, disregulation or
overproduction may also induce autoimmune pathology.
Inflammatory cytokines
In addition to IFN signaling, inflammatory cytokine and chemokines also play a
role in control of viral replication. Both dendritic cells (DC) and macrophages produce
TNFα, IL-6, MCP-1, and IL-12 in response to viral infection. In addition these same
inflammatory cytokines are often detected in the serum of virally infected animals.
Inflammatory cytokines activate the vascular endothelium as well as stimulate the
recruitment of immune cells such as monocytes and neutrophils. IL-6 has been shown to
be important to limit damage during CVB infection96, while TNFα has been shown to
lead to enhanced pathogenicity with the same virus97. These results demonstrate that
although the inflammatory response is important in the clearance of viral infection, a
prolonged inflammatory state can also lead to adverse reactions including necrosis of
local tissue and autoimmune diseases, so careful regulation is critical.
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Sensors involved in detection of viral products
The innate immune response provides protection during the early stages of viral
infection. However, activation of both the cellular and cytokine responses requires the
host to recognize an ongoing infection. To accomplish this, organisms take advantage of
pathogen associated molecular patterns (PAMP), which are specific for microbial
components typically seen in the context of infection. These PAMPs are recognized by
pattern recognition receptors (PRR) of the innate immune system that rapidly signal for
the initiation of the antiviral response. Two distinct groups of PRRs include the Rig-I
like receptors (RLR) and the Toll-like receptors (TLR). These two pathways, along with
other components, provide a means for cells to detect the presence of viral pathogens.

Rig-I like receptors
RLRs are cytoplasmic proteins that recognize viral products that have gained
access to the cytosol. There are currently three known members of this family: retinoic
acid-inducible gene I (Rig-I), melanoma differentiation-associated gene 5 (MDA5), and
laboratory of genetics and physiology-2 (Lgp2)98. Rig-I and MDA5 both contain a
DExD/H box helicase domain that binds double stranded RNA (dsRNA) and two Nterminal caspase recruitment (CARD) domains involved in signaling 99-102. Lgp2
contains the helicase domain, but lacks the CARD domains, and was originally thought to
be a negative regulator 103,104. However, recent reports indicate that it may have an
activating function in response to certain viruses105,106. Both Rig-I and Lgp2 also contain
a C-terminal repressor domain that blocks signaling in the absence of ligand binding 102.
Rig-I binds preferentially to ssRNAs that are phosphorylated at the 5’ end 107,108 and
15

contain homopolyuridine or homopolyriboadenine motifs as well as short dsRNA 109-111.
MDA5 recognizes long dsRNAs and does not require 5’ phosphorylation 110-113.
Crystallization studies have determined that the differential ligand binding capacities of
Rig-I and MDA5 are dependent on structural differences in the C-terminal domain of the
protein114,115. The different ligand preferences of the two proteins is thought to result in
specificity for the recognition of individual viruses.
Both MDA5 and Rig-I signal through CARD-CARD interactions with IPS-1 (also
known as MAVS, VISA, or Cardiff), which is located on the outer mitochondrial
associated membrane 116-119. Downstream of IPS-1 120, TRAF3 activates TBK1 and
IKKe, which phosphorylate IFN regulatory factor 3 (IRF-3) and IRF-7 121,122. Activated
IRF-3 and IRF-7 translocate into the nucleus and bind IFN stimulated response elements
(ISREs), inducing the expression of type I IFNs 123. IPS-1 also interacts with FASassociated death domain-containing protein (FADD) 124. FADD activates caspases-8 and
-10, and the activation of the caspase death effector domains activates NF-kB, leading to
the production of inflammatory cytokines 125. A schematic of RLR signaling is shown in
Figure 1.1.

Toll like receptors
TLRs are transmembrane proteins that contain luminal leucine-rich repeats
(LRRs) that sense pathogen associated molecular patterns and cytoplasmic Toll/IL-1
receptor homology (TIR) domains that signal through downstream adaptors 98. There are
10 members of the TLR family in humans and 13 in mice. TLRs involved in the
detection of viral nucleic acids are located on the cell surface (TLR3) or in endosomal
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compartments (TLR3, 7, 8, and 9) 126. TLR3 recognizes dsRNA, which constitutes the
genome of dsRNA viruses and is also an intermediate produced during replication of
single stranded (ss) RNA viruses 127. TLR7 and 8 recognize ssRNA as well as
imidazolequinilone compounds, which are known to have antiviral properties 126,128-131.
TLR9 recognizes unmethylated CpG-containing DNA, which is commonly found in the
genomes of DNA viruses132,133.
TLR3 signals through the adaptor protein TRIF 134,135. TRIF interacts with
TRAF3 and TRAF6 through TRAF-binding motifs and with RIP1 and RIP3 through
RHIM motifs 136-138. TRAF3 leads to the secretion of type I IFNs, while TRAF6 and
RIP1 lead to NF-kB activation and production of inflammatory cytokines 139. TLR7, 8,
and 9 signal through the adaptor protein myeloid differentiation primary-response gene
88 (MyD88). MyD88 contains a TIR domain as well as a death domain that allows it to
serve as an adaptor for TLR signaling. MyD88 associates with a signaling complex
consisting of TRAF6, BTK, IRAK4, and IRAK1 140. Signaling through this complex
activates IRF7, NF-kB, and MAP kinase pathways 141-143. Thus, although RLRs and
TLRs signal through different pathways, both appear to be able to activate the production
of type I IFNs (i. e. IFN-a and IFN-b) and inflammatory cytokines.
Two additional TLR family members that signal through MyD88 have been
implicated in the recognition of non-nucleic acid viral components. TLR2 is known to
detect a variety of lipoproteins as well as yeast-associated zymosan, however, it has also
been demonstrated to have a role in the recognition of viral envelope proteins 144. A
recent study has also described a role for TLR2 in detection and the early IFN response to
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poxvirus infection145. Similarly, while TLR4 has traditionally been known as the sensor
of LPS, it can also respond to viral-derived envelope glycoproteins 146.

1.9 Additional sensors (non-TLR, RLR)
The TLRs and RLRs have been shown to play a role primarily in RNA virus
infection. Recently, the array of innate immune sensors of viral infection has been shown
to include additional cytosolic proteins that are involved in the recognition of DNA
viruses. A DNA binding protein, named DNA-dependent activator of IFN-regulatory
factors (DAI), Z-DNA binding protein 1 (ZBP1), or DLM-1, binds cytosolic DNA
inducing type I IFN and other genes involved in innate immunity 147,148. Accordingly,
RNA interference of mRNA for DAI in cells inhibits DNA-mediated antiviral responses.
Furthermore, NALP3, a component of the cytosolic molecular complex termed the
inflammasome, has been shown to recognize adenoviral DNA, inducing activation of
caspase 1 and maturation of pro-interleukin-1β in macrophages 149. Correspondingly,
mice lacking NALP3 or its signaling adaptor, ASC, display reduced innate inflammatory
responses to adenovirus particles. Even more recent studies have suggested that Aim2
also recognizes DNA virus infection150. Similar to NALP3, Aim2 activates the
inflammasome pathway leading to IL-1β production. Cells are also known to produce
type I IFN in response to cytoplasmic dsDNA151.

The initial sensor in this pathway is

currently unknown, however, STING is known to play a role in the downstream signaling
pathway152. The discovery of these sensors has provided further insight into the innate
response against DNA viruses.
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Besides RLR and TLR classes of sensors, other proteins are known to detect viral
products and contribute to the immune response, especially RNase L and protein kinase R
(PKR). RNase L has recently been reported to be involved in the RLR response to viral
nucleic acids 153. It is proposed that 2’,5’-linked oligoadenylate generated by viral
infection activates RNase L to cleave self RNA into small RNA products, which are
responsible for RLR signaling. However, it is not yet known how these small self-RNAs
are recognized by MDA5 and RIG-I. PKR has been shown to dimerize upon binding of
dsRNA. The activated PKR dimer phosphorylates eukaryotic initiation factor 2-a (eIF2a) which results in inhibition of translation, preventing viral replication 154. Recent
results indicate that PKR is also necessary for the stabilization of type I IFN mRNA
transcripts155. Like RLRs, RNase L and PKR are upregulated in response to type I IFN,
demonstrating their important role in the pre-programmed antiviral response.

The role of RLRs and TLRs in viral infection
RLRs
Among the RLRs, ligand preferences appear to determine which virus is
recognized by which sensor. The current paradigm is that RIG-I recognizes RNA
containing 5’-triphosphates, while MDA5 recognizes dsRNA. Therefore it is not
surprising that RIG-I has been shown to detect Influenza A and B viruses, vesicular
stomatitis virus (VSV), and some Flaviviruses (Japanese Encephalitis Virus and Hepatitis
C Virus) 112,156,157. Likewise, MDA5 detects picornaviruses such as encephalomyocarditis
virus (EMCV), Mengo virus and Theilers virus 112,113. These viruses contain a 5’ VPg
cap instead of 5’triphosphate and make large amounts of dsRNA during replication.
19

However, other results do not neatly fit this paradigm. RIG-I and MDA5 play redundant
roles in the recognition of West Nile Virus 158, Dengue virus, 157 paramyxovirus, and
reovirus 157, most of which contain 5’triphosphates. In addition, although sendai virus
has been shown to activate RIG-I, it encodes for a protein, the V protein, that is a specific
inhibitor of MDA5 159. Furthermore, murine hepatitis virus, a member of the coronavirus
family that does not contain VPg has recently been shown to be recognized by MDA5160.
One explanation is that although RIG-I preferentially recognizes 5-triphosphates and
polyuridine rich regions, it can also recognize short dsRNA, while MDA5 recognizes
long dsRNA 110. The ability of MDA5 and Rig-I to specifically detect certain viruses,
while also detecting common pathogens illustrates the need for multiple sensors to
recognize and control the wide variety of viral pathogens.

TLRs
Compared to the RLRs, the role of TLRs in anti-viral responses is more intricate
161,162

. TLR3 was originally shown to detect dsRNA127. Accordingly, TLR3 has been

implicated in the detection of several RNA viruses such as EMCV 163, CVB 70, RSV
164,165

, West Nile Virus 166, and Punta Toro Virus 167. However, in another study TLR3

did not contribute to viral pathogenesis in vesicular stomatitis virus (VSV), lymphocytic
choriomeningitis virus (LCMV) and reovirus infections 168. In addition, TLR3 has been
implicated in recognition of DNA viruses. TLR3-deficient mice are more susceptible to
MCMV infection than wild type mice169 and have defective T cell responses to HSV170.
Thus, TLR3 may recognize not only RNA viruses, but also DNA viruses, most likely
through RNA intermediates that are generated during viral replication.
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TLR7 has been shown to contribute to the detection of RSV, Sendai virus,
influenza, HIV, VSV, and Coxsackie virus B3 (CVB3) 171, while TLR8 has been
implicated in detection of influenza and paramyxovirus as well as HIV 129,146,172. TLR9
plays a role in recognition of Herpes Simplex virus and cytomegalovirus infection 169,173175

. TLR2 and 4 have been shown to play a role in the recognition of enveloped viruses.

Both Herpesviruses, which contain a DNA genome, and RSV, which has a ssRNA
genome, have been reported to be recognized by these sensors 176-178. In summary, TLR7
and 8 recognize ssRNA viruses, while TLR9 recognize DNA viruses. TLR2 and 4
recognize enveloped viruses, while TLR3 plays a role in recognition of both RNA and
DNA viruses. Overall, TLR viral specificities exhibit a significant overlap with those of
RLRs.

Pattern recognition receptors in human disease
Recent studies have implicated the dsRNA sensors MDA5 and TLR3 in human
diseases. Genome-wide analysis of single nucleotide polymorphisms (SNPs) identified a
polymorphism in the gene encoding human MDA5, interferon induced helicase 1 (Ifih1),
that is associated with an increased risk of T1DM179. This polymorphism, A946T, is
located near the N-terminus of the protein in an area that has been suggested to be a
regulatory region in Rig-I and LGP-2. This suggested that a genetic predisposition to
T1DM may occur from an altered capacity to either detect viral infection or regulate IFN
production through MDA5. More recent studies indicate that very rare polymorphisms in
Ifih1, which result in inability to produce IFN in response to virus or dsRNA, are
protective for T1DM180,181. This strengthens the link between viruses and diabetes and
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suggests that IFN production by MDA5 may be a pathogenic instigator of T1DM.
Meanwhile, another recent human study demonstrated that a dominant negative form of
TLR3 causes susceptibility to neonatal Herpes Simplex-1 Encephalitis (HSE) 182. This
report indicates that TLR3 plays a role in protection in humans from viral infections,
although whether TLR3 signaling is important for additional viruses remains to be seen.

Conclusions
PRRs such as MDA5 and TLR3 play important roles in control of viral infection
and have been implicated in human diseases. Although much has been learned about the
downstream signaling pathways and molecular ligands associated with these proteins,
how they function in vivo remains poorly understood. In this study, we will describe the
investigation of MDA5 and TLR3 function in several in vivo systems. Chapter 2 focuses
on understanding how MDA5 and TLR3 control MNV-1 infection. In Chapter 3, we
make use of an EMCV infection model to study the role of MDA5 and TLR3 in
myocarditis and diabetes. Chapter 4 describes how MDA5 and TLR3 contribute distinct
functions in NK cell activation by dsRNA. Finally, Chapter 5 will describe how this
work has contributed to our knowledge of how MDA5 and TLR3 function in vivo as well
as potential applications for future studies.
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Figure Legends
Table 1.1. Diseases Caused by Picornavirus and Calicivirus Family Members
List of common diseases caused by picornaviruses and caliciviruses.
Figure 1: Cytoplasmic and Endosomal Sensors of Viral Nucleic Acids
This figure illustrates the detection of viral products by RLR and TLR family members
and the downstream signaling pathways leading to IFN and inflammatory cytokine
production.
It has been published in:
McCartney SA, Colonna M. Viral Sensors: diversity in pathogen recognition. Immunol
Rev. 2009 Jan; 227(1):87-94.
Reprinted with permission. Copyright 2009.
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Table 1.1: Diseases Caused by Picornavirus and Calicivirus Family Members
Virus

Disease

Picornaviruses
Poliovirus

Poliomyelitis

Coxsackievirus A

Hand Foot and Mouth Disease,
Meningitis, Conjunctivitis

Coxsackievirus B

Myocarditis, diabetes

Echovirus

Myocarditis, Meningitis

Rhinovirus

Common cold

Hepatitis A virus

Hepatitis

Foot and Mouse Disease Virus

Foot and Mouth Disease

Encephalomyocarditis Virus

Myocarditis, Encephalitis

Caliciviruses
Norwalk virus (norovirus)

Gastroenteritis

Sapporo virus

Gastroenteritis
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Figure 1.1
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CHAPTER 2

MDA5 Recognition of a Murine Norovirus

This chapter has been published as:
McCartney SA, Thackray LB, Gitlin L, Gilfillan S, Virgin HW, Colonna M. MDA-5
Recognition of a Murine Norovirus. PLoS Pathog 4(7), Jul 2008: e1000108.
doi:10.1371/journal.ppat.1000108

Reprinted with permission
Copyright 2008.
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Abstract
Noroviruses are important human pathogens responsible for most cases of viral epidemic
gastroenteritis worldwide. Murine norovirus-1 (MNV-1) is one of several murine
noroviruses isolated from research mouse facilities and has been used as a model for
human norovirus. MNV-1 infection has been shown to require innate immunity for
clearance, however, the initial host protein that recognizes MNV-1 infection is unknown.
Because noroviruses are RNA viruses, we investigated whether MDA5 and TLR3,
cellular sensors that recognize dsRNA, are important for the host response to MNV-1.
We have shown that MDA5 but not TLR3 deficient dendritic cells(DC) have a defect in
cytokine response to MNV-1. In addition, MNV-1 replicates to higher levels in MDA5 /- DCs as well as in MDA5 -/- mice in vivo. This is the first demonstration of an innate
immune sensor for norovirus. Knowledge of the host response to MNV-1 may provide
keys for prevention and treatment of the human disease.
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Author Summary
Gastroenteritis is a common disease in both developed and developing countries.
The two main causes of this affliction are bacteria and viruses. The primary viruses
implicated in gastroenteritis are a family of viruses called noroviruses, which include
Norwalk virus, notorious for several recent outbreaks on cruise ships. We are interested
in how the innate immune system detects viral infection and signals the body to respond
to the threat. To learn more about this we studied two classes of proteins, both of which
are thought to detect signs of viral infection. We discovered that one of these proteins,
Melanoma differentiation associated protein-5 (MDA-5), is responsible for detecting a
mouse norovirus that is similar to the human pathogen. These findings allow us to better
understand the pathogenesis of norovirus infection and may provide clues for controlling
the human disease.
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Introduction
Norwalk virus and other human noroviruses are common human pathogens responsible
for most of the nonbacterial epidemic gastroenteritis in both developed and developing
countries[Estes, 2006 #6; Widdowson, 2005 #12; Lopman, 2004 #10; Fankhauser, 1998
#8; Mead, 1999 #11]. In humans, norovirus infection results in vomiting, diarrhea, fever,
malaise, and abdominal pain within 24 hours after infection. These symptoms usually
clear within 48 hours, but the virus can persist for 3-6 weeks post-infection[Dolin, 2004
#9; Graham, 1994 #23]. Until recently the lack of ability to culture the virus has
prevented us from investigating its pathogenicity. The discovery and subsequent culture
of murine norovirus-1 (MNV-1) has led to advances in understanding of both the viral
lifecycle as well as the host response to infection[Wobus, 2004 #2; Karst, 2003 #19].
Noroviruses are in the Calicivirus family and are nonenveloped viruses containing
a single-stranded positive-sense RNA genome. This genome is covalently linked at the
5’ end to the viral nonstructural protein VPg[Green, 2001 #31]. It encodes four open
reading frames (ORFs)[Jiang, 1993 #20; Lambden, 1993 #21; Clarke, 2000 #22;
Thackray, 2007 #1]. ORF1 encodes a polyprotein that is cleaved into at least six
nonstructural proteins by the viral 3C-like protease[Blakeney, 2003 #43; Liu, 1996 #45;
Liu, 1999 #46; Sosnovtsev, 2006 #44]. ORF2 encodes the major capsid protein, viral
protein 1[Prasad, 1999 #47; Jiang, 1993 #20], while ORF3 encodes the small basic
protein, viral protein 2[Bertolotti-Ciarlet, 2002 #48; Glass, 2000 #49]. OFR4 was
recently discovered and has yet to be characterized[Thackray, 2007 #1].
The rapid clearance of MNV-1 infection indicates an important role for the innate
immune system, since clearance occurs before the typical initiation of adaptive
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immunity[Mumphrey, 2007 #5]. Previous work has revealed that MNV-1 infection of
mice lacking either the type I and type II interferon (IFNα/β/γ) receptors or the STAT-1
molecule is lethal [Mumphrey, 2007 #5; Karst, 2003 #19]. Several proteins are known to
initiate the IFN response to viruses[Takeuchi, 2007 #63], including Toll-like receptors
(TLR)[Iwasaki, 2004 #42], Rig-I-like helicases (RLH)[Sumpter, 2005 #38; Pichlmair,
2007 #51], PKR[Garcia, 2007 #32], and RNase L[Malathi, 2007 #15]. However, the
initial sensor responsible for recognition of noroviruses and subsequent activation of
cytokine response has not been determined.
TLRs are located on the plasma membrane and in endosomal compartments. Among the
TLRs, TLR 7 and 8 recognize ssRNA[Lund, 2004 #36; Heil, 2004 #41; Diebold, 2004
#52], TLR9 recognizes DNA[Bauer, 2001 #39; Hemmi, 2000 #53], while TLR3 signals
in response to dsRNA[Alexopoulou, 2001 #54]. The RLHs are cytoplasmic sensors
located intracellularly[Pichlmair, 2007 #51], which include Rig-I and MDA-5[Takeuchi,
2007 #24] [Fujita, 2007 #35; Yoneyama, 2004 #55] and signal through IPS1/MAVS/Cardiff/VISA[Xu, 2005 #61; Meylan, 2005 #60; Sun, 2006 #59]}[Perry, 2005
#62]. Rig-I has recently been shown to preferentially recognize 5’-phosphorylated
RNA[Hornung, 2006 #26; Pichlmair, 2006 #27], while MDA5 responds to dsRNA
[Yoneyama, 2005 #37]. Recently it has been shown that the lack of Rig-I does not confer
susceptibility to human norovirus in vitro[Guix, 2007 #7]. Because MDA5[Loo, 2008
#17; Kato, 2006 #13; Gitlin, 2006 #18; Fredericksen, 2008 #58], and possibly TLR3
[Edelmann, 2004 #56; Wang, 2004 #57] have been shown to play a role in host response
to other RNA viruses we investigated if these sensors might be involved in MNV-1
recognition.
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Results
MDA-5 is required for cytokine response to MNV-1 by Bone Marrow-Derived DC.
Previous studies have shown a requirement for the type I IFN response for control of
MNV-1 infection[Wobus, 2004 #2]. Since both MDA5 and TLR3 have been shown to be
involved in type I IFN and cytokine signaling in response to infection with other viruses,
we were interested to see if they may play a role in MNV-1 infection.
MNV-1 infection has a limited cell tropism- infecting only DC and macrophage
lineages in vitro[Wobus, 2004 #2; Ward, 2006 #50]. In order to test whether the MDA5
or TLR3 sensors were important, BMDCs from Wild Type as well as TLR3 -/- and
MDA5 -/- mice were cultured for 7 days and then stimulated with various MOI of MNV1 isolates. After 24 hours supernatants from the in vitro infections were harvested and
tested for cytokine production.
Interestingly, although WT and TLR3 DCs produced similar levels of IFNα and
inflammatory cytokines in response to MNV stimulation, MDA5 deficient DCs produced
significantly less IFNα, IL-6 , MCP-1 and TNFα (figure 1) and IFNβ (data not shown).
This indicates a role for MDA5 in the detection of MNV-1 infection.
MNV-1 replicates more efficiently in MDA-5 deficient DCs. Because the MDA5 -/BMDCs had a defect in cytokine response to MNV-1, we wanted to test if this deficiency
had an effect on the course of viral infection. To address this issue, we infected BMDCs
in vitro with MNV-1 and harvested samples at 6-hour time-points post-infection. The
infections were done at a saturating and non-saturating MOI to test for effects on viral
replication and spreading.
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Viral titers were identical in WT and MDA5 KO mice up to 12 hours post-infection at a
saturating MOI (figure 2a). However, starting at 18 hours pi, titers from MDA5 KO
BMDCs began to increase over WT BMDCs, and leveled out to a 1-log difference at 24
and 48 hours. At a lower MOI there was no significant difference between viral titers in
the WT and KO cells until the 48-hour time point (figure 2b). At both MOIs the kinetics
of MNV-1 infection appears similar in WT and MDA5 -/- BMDCs; the difference mainly
appears to be in the total amount of viral replication seen in the KO BMDCs. These
results as well as the defect in cytokine response seen previously provide further evidence
for the role of type I IFN (IFNα IFNβ) in preventing MNV-1 growth.
MDA5 limits MNV-1 replication in vivo. MNV-1 infection naturally occurs after fecaloral transmission[Wobus, 2004 #2]. In order to show that MDA5 plays a role in MNV-1
detection in vivo we infected WT or MDA5 -/- mice with MNV-1.CW3 perorally.
Organs were then harvested from infected as well as mock-infected mice on days 1, 3,
and 5 post-infection and viral titers were determined for each sample.
At d3 post-infection MDA5 KO animals had a one log increase in viral titers
compared to wild type animals in the mesenteric lymph nodes, spleen, and proximal
intestine (figure 3). Minimal or negative titers were seen in distal intestine, and stool as
well as liver and lung (data not shown) by viral plaque assay in both WT and MDA5 KO
animals, indicating that MNV-1 infection remained locally contained. Consistent with
lack of systemic infection, serum samples taken at d1, 3, and 5 timepoints post-infection
were found to be negative for IFNα and IFNβ (data not shown). Organs harvested at d1
and d5 also contained minimal detectable levels of MNV-1 in both WT and MDA5 KO
mice indicating that the infection developed and was cleared in the timeframe that has
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been reported earlier[Mumphrey, 2007 #5]. Similar to our in vitro data, the kinetics of
MNV-1 infection is similar in WT and MDA5 -/- mice in vivo, while there is a significant
increase in maximum titers in the KO animals. This suggests that MDA5 controls the
amplitude of infection.
MDA-5 recognizes replication competent viral RNA. Although MDA5 detects
norovirus, it is unclear which RNA feature is essential for recognition. Rig-I recognizes
viruses through 5’-phosphorylation, however, in norovirues this feature is absent because
of a 5’ VPg cap[Green, 2001 #31]. To test whether 5’ RNA configuration is essential for
MDA5 recognition we infected BMDCs with MNV and then harvested the total RNA
from infected as well as mock-infected cells before peak infection to isolate potential
intermediates. BMDCs from WT or MDA5 deficient mice were then stimulated with the
harvested RNA, as well as RNA treated with calf intestinal phosphatase (CIP,) which
removes 5’ phosphates, and proteinase K (PK), which degrades proteins including VPg
and prevents viral replication in vitro[Guix, 2007 #7].
Both WT and MDA5 -/- DCs produced limited inflammatory cytokines in
response to mock-infected RNA, however, WT but not KO BMDCs produced large
amounts of TNFα and IFNβ in response to RNA from MNV-infected cells (figure 4).
CIP treatment of the RNA had no significant effect on cytokine production in either cell
type, as predicted by the existence of VPg instead of 5’ phosphorylation. However, the
addition of PK to the RNA abrogated the cytokine response in WT BMDCs. This
suggests that MDA5 does not recognize naked viral RNA, but either directly recognizes
RNA linked to VPg or recognizes a RNA product generated during viral replication.
Because MDA5 has been previously shown to recognize uncapped poly I:C[Kato, 2006
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#13; Gitlin, 2006 #18], it is most likely that the PK effect reflects the requirement for
viral replication and the subsequent generation of RNA species that are recognized by
MDA5.
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Discussion
We have provided the first description of an initial sensor of norovirus infection. MDA5
recognizes MNV-1 and stimulates antigen presenting cells to produce type I interferon as
well as IL-6, MCP-1, and TNFα that function to recruit other immune cells as well as
activate antiviral pathways in host cells. Deficiency of this sensor results in lack of
cytokine production as well as increased MNV-1 replication in deficient cells and mice.
It is interesting to note that although MDA5 deficient cells have a defect in IFNα
production, the mice do not have as severe a phenotype as the IFNαβγR or Stat1 deficient
mice. These mice completely lose the ability to respond to IFN because they lack either
its receptor or a critical downstream signaling molecule. As a result these mice have
widespread MNV-1 dissemination that often results in lethality. The more mild
phenotype seen in the MDA5 KO mice resembles that seen in the IFNαβR KO mice and
likely results from the retained ability of IFNγ production. Additionally, it is also
possible that other sensors of viral products or cell damage are able to respond and trigger
an IFN and cytokine response. Further investigation is needed to determine if mice that
are deficient in multiple nucleic acid sensors lack all ability to respond to MNV-1 and
whether they therefore have a more severe phenotype. Data from our lab and
others[Guix, 2007 #7] from in vitro experiments suggest that TLR3 and Rig-I are
unlikely candidates for additional MNV-1 sensors, but TLR7 remains to be tested, as
does the role of other sensors in vivo.
Although the putative recognition structure for Rig-I has previously been
determined[Hornung, 2006 #26; Pichlmair, 2006 #27], the RNA structure recognized by
MDA5 in viral infection remains unclear. We demonstrated that MDA5 recognition of
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MNV RNA is abrogated by treatment with PK, which degrades VPg, preventing viral
replication. This suggests that MDA5 does not recognize naked RNA, but rather a RNA
intermediate that is abundantly generated during replication. Although we cannot rule
out the possibility that MDA5 recognizes the VPg-RNA structure itself, this is unlikely
because MDA5 is known to respond to poly I:C which has no protein cap. Learning
more about which viruses are recognized by MDA5 may provide hints as to what this
protein recognizes. This information could then be used to design adjuvants to
manipulate the immune response for both vaccine design as well as in viral infection.

51

Materials and Methods
Cell Lines. RAW264.7 cells were maintained in Dulbecco modified Eagle medium
(DMEM) supplemented with 10% fetal calf serum (Hyclone), 100U penicillin/ml,
100µg/ml streptomycin, 10 mM HEPES, and 2 mM L-glutamine.
Bone Marrow-derived DC. Bone marrow was flushed from the femurs of mice and
cultured as described previously[Barchet, 2005 #28]. Briefly, cells were cultured in
RPMI (Gibco) with 10% fetal calf serum (Hyclone), Glutamax, Na Pyruvate, NonEssential AAs, and Kanamycin for 7-8 days at 37 degrees.
Mice. MDA5 -/- mice were described previously[Gitlin, 2006 #18]. For the infection
studies mice backcrossed onto a pure 129/SVJ background were used. Control WT mice
were age and sex matched and were obtained from littermate controls and from Jackson
Lab for 129/SVJ. TLR3 -/- mice were kindly provided by Richard Flavell [Alexopoulou,
2001 #29]. All mice were bred and housed in a pathogen free facility and regularly tested
for MNV-1 antibodies.
In vitro stimulations. BMDCs were counted and plated at 200,000 cells/well in a 96
well plate. MNV-1 was added at various MOI to the cultures, or alternatively 500ng
RNA was complexed with lipofectamine 2000 (invitrogen) and added according to
manufactures instructions. After 20-24 hours supernatants were harvested and stored at 20 degrees until cytokine analysis. IFNα and IFNβ levels from the supernatants were
measured by ELISA (PBL Biomedical Laboratory, New Brunswick, NJ), while IL-6,
MCP-1, and TNFα levels were determined by cytokine bead array (BD Biosciences).
In vivo infections. WT or MDA5 KO mice were infected perorally with 1X107 PFU
MNV1.CW3[Thackray, 2007 #1] or mock-infected with media only. Three days post-
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infection the following organs were harvested and stored at -80 degrees until assayed:
spleen, liver, mesenteric lymph node, lung, proximal intestine, distal intestine, stool, and
serum.
MNV-1 plaque assay. Tissue samples were homogenized in 1 ml complete DMEM by
bead beating with 1.0-mm zirconia/silica beads (BioSpec Products, Inc.). Tissue
homogenates were diluted 1:10 in complete DMEM and tested for viral titers by using a
plaque assay that has been previously described [Wobus, 2004 #2]. Briefly, 2X106
RAW264.7 cells were seeded into each well of six-well plates, and infected the next day
with 10-fold dilutions of tissue homogenate in duplicate. After a 1-hr infection, the
inoculum was removed and wells were overlaid with 1.5% SeaPlaque agarose
(Cambridge Biosciences) in complete minimal essential medium and incubated at 37C.
After 48 hrs, a second overlay was added containing 1.5% SeaKem agarose (Cambridge
Biosciences) and 0.01% neutral red in complete minimal essential medium. After 8 hrs,
plaques were then visualized.
RNA preparation. 5*106 BMDC were infected with MNV-1 at MOI 1 or mock-infected
for 10 hours. Total RNA was harvested using the Genelute Total RNA Isolation Kit
(Sigma). Purified RNA was incubated with either 10 units Calf Intestinal Phosphatase
(New England Bioloabs) in NEB buffer 2 or with 200µg/ml proteinase K (Sigma) in
0.1M NaCl, 10mM Tris (pH 8), 1mM EDTA, 0.5% sodium dodecyl sulfate or left
untreated for one hour at 37 degrees then precipitated with LiCl (Ambion), washed, and
resuspended for stimulations.
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Figure Legends
Figure 2.1: MDA5 is required for cytokine response to MNV in vitro. Bone marrowderived dendritic cells from wild type, TLR3 KO, or MDA5 KO mice were stimulated in
vitro with MNV at the indicated MOI. 24 hours later, cell culture supernatants were
harvested and examined for IFNα by ELISA or for IL-6, TNFα, and MCP-1 by cytokine
bead array. Data shown is the average of three independent experiments. Statistical
analysis was done using student’s t test where * = p<0.05, ** = p<0.01, and *** =
p<0.001.

Figure 2.2: MDA5 deficiency leads to increased MNV titers in vitro. Bone marrowderived dendritic cells from wild type or MDA5 KO mice were infected with MNV at
MOI 5 or 0.05. Samples were taken at 6-hour time-points and stored at -80 degrees.
Viral titers were determined in duplicate on RAW cells for each sample and statistical
significance was determined using student’s t test. Data shown is the average of four
independent experiments.

Figure 2.3: MNV replicates more efficiently in MDA5 KO hosts. Wild type or MDA5
deficient mice were inoculated perorally with 1X107 PFU MNV-1.CW3 or mock infected
with media only. Organs were harvested 3 days post-infection and viral titers of
Mesenteric Lymph Node (MLN), Spleen , Proximal Intestine (prox intest), Distal
Intestine (dist intest), and Stool were determined by viral plaque assay. Statistical
significance was calculated using the Mann Whitney test, and P values comparing
infection between WT and MDA5 KO mice are as follows: MLN P<0.0001; Spl
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P=0.0003; PI P=0.0002. Mock-infected animals showed no detectable MNV-1 at all
time-points tested. Data shown is from at least 9 animals.

Figure 2.4: Proteinase K and RNase abrogates MDA5 recognition of viral RNA.
WT or MDA5 -/- BMDCs were stimulated with RNA from MNV infected or mock
infected lysates that was treated with CIP, PK or untreated. After incubation for 20
hours, supernatants were harvested and cytokines analyzed with CBA and IFNβ ELISA.
Data shown is from three independent experiments and statistics were calculated by
student’s t test
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Chapter 3
RNA Sensors in Myeloid Cells Prevent Virus-Induced Diabetes

This chapter has been submitted for publication as:
McCartney SA, Vermi W, Lonardi S, Rossini C, Otero K, Calderon B, Gilfillan S,
Diamond MS, Unanue ER, and Colonna M. RNA sensors prevent virus-induced diabetes
in mice.
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Abstract
Viruses have long been implicated in the etiology of type I diabetes mellitus (T1DM).
This association was further strengthened by the finding of genetic susceptibility to
T1DM associated with polymorphisms in the human gene encoding MDA5, a dsRNA
sensor involved in the recognition of viral infection.

In addition to MDA5, the

endosomal dsRNA sensor TLR3 has also been implicated in animal models of diabetes
and viral infection. It has been suggested that these sensors may induce T1DM through
the production of type I IFN in response to infection, which may lead to increased
stimulation of autoimmune T cells. In this study we addressed the relative contributions
of MDA5 and TLR3 to the host response to picornavirus infection and diabetes using a
model of encephalomyocarditis virus strain D (EMCV-D).

By analyzing EMCV-D

infection in MDA5-/-, TLR3-/- and MDA5-/-TLR3-/- double knockout (DKO) mice we
found that MDA5 and TLR3 have different impacts in the control of viral infection and
tissue damage in heart and pancreas. EMCV-D infection caused primarily heart damage
in MDA5-/- mice but severe diabetes in TLR3-/- mice.

We further determined that the

development of diabetes in the TLR3-/- animals was due to virus-induced β-cell damage
rather than T cell-mediated autoimmunity, and resulted from the impaired capacity of
hematopoietic cells, especially DC, to induce an early IFN-β response that restricts β-cell
infection. These findings indicate that IFN produced by dsRNA sensors limits diabetes
induced by viral infection, and provides evidence that these proteins can be protective as
well as pathogenic.
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Introduction
Innate immune responses to viruses depend on molecular sensors that promptly detect
viral products and trigger the secretion of type I interferons, i.e. IFN-β and IFN-α
(Takeuchi and Akira 2007). Two types of sensors detect double-stranded (ds) RNA
generated during infection with RNA viruses: Toll-like receptor (TLR) 3 and RIG-I-like
receptors (RLR). TLR3 senses the dsRNAs that reach the endosomal compartment due to
the phagocytosis of virally infected cells(Kawai and Akira). RLRs include two IFNinducible helicases, MDA5 and RIG-I, which sense the dsRNAs that are generated in the
cytoplasm during viral replication. MDA5 specializes in the detection of picornaviruses,
whereas RIG-I senses most of the other RNA viruses(Yoneyama and Fujita 2009). These
viral specificities depend on the ability of MDA5 and RIG-I to detect RNA molecules
with different lengths, structures, and 5’ caps (Cui, Eisenacher et al. 2008; Kato,
Takeuchi et al. 2008; Saito and Gale 2008; Takahasi, Kumeta et al. 2009).

TLR3 deliver its intracellular signal through the adaptor TRIF, activating the
transcription factor IRF3, which induces IFN-β production(Yamamoto, Sato et al. 2002).
RIG-I and MDA5 signal through another adaptor, IPS-1, that activates IRF3 and IRF7,
inducing both IFN-β and IFN-α production(Kawai, Takahashi et al. 2005; Meylan,
Curran et al. 2005; Seth, Sun et al. 2005; Xu, Wang et al. 2005). A third RLR, Lgp2,
detects dsRNA but does not contain signaling domains and is thought to positively
regulate MDA5 and negatively regulate RIG-I (Satoh, Kato et al.; Rothenfusser,
Goutagny et al. 2005; Venkataraman, Valdes et al. 2007). Type I IFNs induce an antiviral
state in uninfected cells and promote apoptosis of infected cells, limiting viral replication
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and spreading(Garcia-Sastre and Biron 2006). Moreover, type I IFNs promote subsequent
NK cell, T cell and B cell responses(Stetson and Medzhitov 2006), facilitating complete
viral clearance.

Type I diabetes (T1DM) is an autoimmune disease caused by selective destruction of βcells of the endocrine pancreas by autoreactive T cells. Although predisposing genetic
factors, particularly MHC class II, play a predominant role in the pathogenesis of T1DM,
clinical (Yoon, Austin et al. 1979; Hyoty, Hiltunen et al. 1995; Andreoletti, Hober et al.
1997; Ylipaasto, Klingel et al. 2004) and experimental (Craighead and McLane 1968;
Yoon, McClintock et al. 1980; Guberski, Thomas et al. 1991)studies have suggested that
viral infections may contribute to T1DM, particularly infections by RNA viruses such as
Coxsackie B4 and enteroviruses. These viruses may induce T1DM by causing β-cell
damage and subsequent release of autoantigens that induce and/or trigger autoreactive T
cells(Horwitz, Ilic et al. 2002). Additionally, excessive type I IFN and cytokine response
to viral infection can activate and attract pre-existing autoreactive T cells that have
escaped thymic selection (von Herrath 2009). Consistent with a diabetogenic role of type
I IFN response to viruses, genetic studies have recently showed that resistance to T1DM
is highly associated with MDA5 polymorphisms that reduce response to dsRNA
(Nejentsev, Walker et al. 2009; Shigemoto, Kageyama et al. 2009). Additional studies
demonstrated that TLR3 activation by synthetic dsRNA precipitate disease in mouse
models of T1D (Wen, Peng et al. 2004; Lang, Recher et al. 2005). Altogether, these
studies suggest that RNA sensors may contribute to the incidence T1DM.
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In this study we addressed the relative contributions of MDA5 and TLR3 in host response
to picornavirus infection and diabetes in the model of encephalomyocarditis virus strain
D (EMCV-D). EMCV-D is picornavirus family member that has preferential tropism for
pancreatic β-cells, and can induce diabetes in selective mice strains such as
DBA/2(Gaines, Kayes et al. 1986; Cerutis, Bruner et al. 1989). EMCV-D, like other
EMCV strains, also induces myocarditis. The role of MDA5 and TLR3 in EMCV
infection has been matter of debate. Initial studies indicated that MDA5 is essential for
protection from EMCV infection, while TLR3 was dispensable (Gitlin, Barchet et al.
2006; Kato, Takeuchi et al. 2006); however, a subsequent study suggested that TLR3
provides protection from EMCV-induced myocarditis (Hardarson, Baker et al. 2007). By
analyzing EMCV-D infection in MDA5-/-, TLR3-/- and MDA5-/-TLR3-/- double knockout
(DKO) mice we found that MDA5 and TLR3 have different impacts in the control of
viral infection and tissue damage in heart and pancreas. EMCV-D infection caused
mainly heart damage in MDA5-/- mice and diabetes in TLR3-/- mice. Remarkably,
diabetes was due to virus-induced β-cell damage rather than T cell-mediated
autoimmunity, and depended on the impaired capacity of hematopoietic cells, especially
DC, to induce an early IFN-β response that restricts β-cell infection. These results
indicate that MDA5 and TLR3 have different impacts on anti-viral responses in distinct
organs because they have different cellular distribution and mediate type I IFN responses
of different magnitude and kinetics.

Moreover, RNA sensors are not always

diabetogenic; in fact their impact depends on the pathogenetic mechanism of diabetes.
While in autoimmune diabetes engagement of RNA sensors by viruses may unveil or
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trigger a latent autoimmune condition, in diabetes caused by direct viral damage of βcells, a normal function of RNA sensors in innate immune cells is essential for protection.
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Results
Both MDA5 and TLR3 contribute to survival from EMCV-D infection
To evaluate the roles of MDA5 and TLR3 in the response to EMCV-D, we infected WT,
MDA5-/-, TLR3-/- and DKO mice with EMCV-D. All mice were on a C57BL/6
background. Similar to previous reports, WT C57Bl/6 mice survived EMCV-D infection;
however, MDA5-/- mice were highly susceptible and died on day 5 post-infection (PI)
(Fig. 1). TLR3-/- mice were also more susceptible to EMCV-D than WT mice, but less
susceptible than MDA5-/- mice, dying on average at day 20 PI with a proportion of mice
surviving infection. The contribution of TLR3 to anti-EMCV-D defense was further
confirmed by the more severe sensitivity of DKO mice to EMCV-D compared to MDA5/-

mice. DKO mice died at day 2 PI (Fig. 1), or at day 3 PI with an extremely low

inoculum of 1 PFU/mouse (data not shown). These data demonstrate that both MDA5
and TLR3 contribute to the containment of EMCV-D infection in vivo although MDA5
appears to have a predominant role over TLR3.

Infection of MDA5-/- and TLR3-/- mice with EMCV-D results in different heart and
pancreatic diseases
Previous studies have implicated MDA5 (Kato, Takeuchi et al. 2006) and TLR3
(Hardarson, Baker et al. 2007) in protection from EMCV-induced viral myocarditis using
different strains of EMCV. To test the relative contributions of MDA5 and TLR3 to the
protection of heart from EMCV-D, we measured serum troponin in WT, MDA5-/-, TLR3/-

, and DKO mice after infection, which reflects the extent of cardiac damage. Similar to

previous findings (Kato, Takeuchi et al. 2006), MDA5-/- mice had highly elevated
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troponin levels by day 4 (Fig. 2A). Correspondingly, the hearts of MDA5-/- mice showed
high EMCV-D titers, marked immunoreactivity for EMCV-D antigens and histological
evidence of myocarditis at this time-point (Fig. 2B and Fig. S1). TLR3-/- mice showed
milder signs of heart infection than MDA5-/- mice. Troponin levels were normal with the
exception of few TLR3-/- mice with elevated troponin at day 7. Heart viral titers were
slightly higher than those of WT mice at all time points, and histopathology was modest
(Fig. 2 and Fig. S1). The contribution of TLR3 to anti-EMCV-D response in the heart
became more evident in the DKO mice, which showed earlier increase in troponin levels,
higher levels of EMCV replication in the heart and stronger immunostaining for EMCV
antigens than MDA5-/- mice. These results indicate that MDA5 plays a dominant role in
the protection from EMCV-D-induced myocarditis, whereas TLR3 contribution is
secondary.

EMCV-D is also known to infect the pancreas, particularly the β-cells of the pancreatic
islets, leading to the development of diabetes in susceptible mouse strains like DBA/2
(Gaines, Kayes et al. 1986). C57Bl/6 mice are normally resistant to EMCV-induced
diabetes, and accordingly WT mice maintained normal serum glucose levels after
EMCV-D infection (Fig. 3A). Additionally, WT mice showed no increase of the
pancreatic enzymes amylase or lipase in the serum, suggesting lack of significant damage
of exocrine pancreas (Fig. 3B). EMCV-D titers in the pancreas were increased at day 1-3
PI but were cleared within a week. Deficiency of MDA5 was not as harmful for the
pancreas as it was for the heart. MDA5-/- mice showed no detectable hyperglycemia and a
slight increase in serum amylase and lipase at day 2 and 4 PI (Fig. 3 and data not shown).
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Viral titers were similar to those of WT animals at day 1 PI, but increased at day 2 PI and
remained elevated until day 4-5 PI, when most of the mice died (Fig. 3). Thus, MDA5 is
essential for EMCV-D control at late rather than early timepoints, most likely because
MDA5 expression must be induced by type I IFN. Similar to MDA5-/- mice, TLR3-/- mice
showed minimal increase in amylase or lipase in the serum (Fig. 3). Surprisingly,
however, TLR3-/- mice developed marked hyperglycemia by day 5 (Fig. 3A) and by day
7 had almost undetectable islet mass as assessed by hematoxylin-eosin staining (Fig. S2).
TLR3-/- mice showed higher viral titers in the pancreas at days 1 and 2 PI compared to
WT and MDA5-/- mice, but normal clearance of EMCV-D by day 7. Thus, TLR3 plays
as role in the early control of EMCV-D infection, which appears to be essential for the
protection of the endocrine pancreas.

Finally, examination of pancreas of DKO mice demonstrated an impressive increase of
serum levels of amylase and lipase as compared to WT mice, which was paralleled by a
large increase in viral titers and extensive destruction of pancreatic architecture in both
the exocrine and endocrine tissue on day 2 (Fig. 3A and S2). This virus-induced
pancreatitis is likely to be the major cause of the death of DKO mice at day 2 PI, given
the comparatively moderate defect in the heart at this timepoint. Despite a severe EMCV
infection of the islets, DKO mice did not develop detectable hyperglycemia, perhaps due
to the concomitant pancreatitis that is rapidly followed by death. Altogether, these results
reveal that MDA5 and TLR3 play partially redundant roles in EMCV-D control in the
exocrine pancreas, such that only DKO mice develop an overt pancreatitis. However,
TLR3 is essential to prevent damage of pancreatic islets, perhaps because of its unique
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role in the early control of EMCV-D infection. MDA5 does control EMCV-D infection at
later timepoints, but it may be too late to effectively protect endocrine pancreas. Overall,
the development of three completely different disease outcomes after infection with the
same dose of EMCV-D demonstrates that MDA5 and TLR3 have different impacts on
anti-viral responses in distinct organs.

EMCV-D-induced β-cell damage in TLR3-/- mice is T cell-independent
T1D is the result of the autoimmune destruction of pancreatic islets by the autoreactive T
cells. EMCV-D-induced diabetes in TLR3-/- mice, however, was not paralleled by an
obvious T cell infiltration of pancreatic islets at any time after infection (data not shown),
making the involvement of an autoimmune mechanism unlikely. At early time points,
pancreatic islets of TLR3-/- mice showed marked staining for viral antigens compared to
WT mice supporting the viral titer data (Fig. 4A). Additionally, islets of TLR3-/- mice
showed marked apoptosis as assessed by staining for caspase 3 (Fig. 4B), and a robust
infiltrate

of

myeloid

cells

that

was

consistent

with

the

presence

of

monocytes/macrophages and/or dendritic cells recruited from either the blood or local
tissue (Fig. 4C). In contrast, WT mice showed only a limited increase of myeloid cells
mostly located around but not within the pancreatic islets. Altogether, the extensive viral
infiltration and apoptosis in the pancreatic islets of TLR3-/- mice suggest that diabetes is
due to failure to control local infection.

TLR3 must be present in the hematopoietic compartment to prevent EMCV-Dinduced diabetes
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We next asked whether TLR3 and MDA5 play their protective roles against EMCV-D
infection by acting directly in the infected tissues or in the innate immune system. To test
this hypothesis, we generated bone marrow chimeras between WT and MDA5-/- mice as
well as between WT and TLR3-/- mice and measured survival and blood glucose after
EMCV-D infection. Survival curves showed that chimeras containing MDA5-/hematopoietic cells and WT stroma (MDA5->WT) were resistant to EMCV-D infection,
while WT->MDA5-/- chimeras were highly susceptible to infection similar to MDA5-/mice. Conversely, TLR3-/-->WT chimeras were more sensitive to EMCV-D infection
than WT->TLR3-/- chimeras, although not as susceptible as WT->MDA5-/- chimeras (Fig.
5A). These results demonstrate that the overall resistance to EMCV-D infection is largely
dependent on MDA5 function in radio-resistant stromal tissues, while TLR3 contributes
to the anti-EMCV-D defense in part, especially in hematopoietic cells. However, the
analysis of blood glucose after EMCV-D infection revealed a quite different picture of
MDA5 and TLR3 impact on the protection of pancreatic islets. TLR3-/-->WT chimeras
developed diabetes after EMCV-D infection, whereas WT->TLR3-/- chimeras as well as
MDA5->WT and WT->MDA5-/- chimeras were protected from diabetes (Fig. 5B). Thus,
protection of endocrine pancreas from EMCV-D infection and diabetes is largely
dependent on TLR3 expression in the radio-sensitive hematopoietic compartment.

Early IFN-β response through TLR3-IRF3 prevents EMCV-D-induced diabetes
The selective impact of TLR3 on the control of EMCV-D-induced diabetes indicated that
TLR3 has a special role in the response to the infection. We noticed that TLR3-/- mice
exhibit higher viral titers than WT and MDA5-/- mice at early timepoints PI (see Fig. 3C).
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In contrast, MDA5-/- mice showed higher viral titers than WT and TLR3-/- mice at late
timepoints (see Figs. 2B and 3C). Thus, we hypothesized that TLR3 may prevent EMCVD-induced diabetes through the induction of type I IFN early after infection. To test this
hypothesis we measured type I IFN in the serum of infected mice using a sensitive
bioassay. In the MDA5-/- mice type I IFN was severely reduced as compared to WT mice;
the residual type I IFN detected in MDA5-/- mice was dependent on TLR3, since no type I
IFN was observed in the serum of DKO mice (Fig. 6A). Thus, the quantitative impact of
MDA5 and TLR3 on type I IFN response is different, MDA5 being responsible for most
of it. MDA5 and TLR3 also contributed differently to the kinetics of type I IFN response.
While type I IFN was detected as early as 15 hours after EMCV-D infection in the serum
of WT and MDA5-/- mice, in TLR3-/- mice was detected only later, suggesting that TLR3
induces an early IFN response to EMCV-D that is essential to protect β-cells.

TLR3-mediated signals activate the transcription factor IRF3, which binds the IFN-β
promoter inducing IFNβ production(Honda, Takaoka et al. 2006). If TLR3-mediated
IFN-β production is necessary to protect from EMCV-D-induced diabetes, one would
expect that mice lacking IRF3 or IFN-β would also develop diabetes after EMCV-D
infection.

To test this, we infected IRF3-/- and IFN-β-/- mice with EMCV-D and

measured blood glucose. Both IRF3-/- and IFN-β-/- mice developed hyperglycemia after
infection. However, both knockout mice were much more susceptible to EMCV-D and
died earlier than TLR3-/- mice (Fig. 6B,C), most likely because a global defect of IRF3
and IFN-β impairs more anti-viral pathways than that triggered by TLR3 only. Since
TLR3 must be expressed in the hematopoietic compartment to protect from diabetes, we
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hypothesized that a defect of IRF3 and IFN-β limited to the hematopoietic compartment
may be sufficient to induce diabetes. To test this, we created IRF3-/-->WT and IFN-β-/->WT bone marrow chimeras, which were then infected with EMCV-D. Both chimeras
developed hyperglycemia after infection, and had a mild survival defect similar to the
TLR3-/- chimeras (Fig. 6D,E). This data strongly supports the hypothesis that early IFNβ production by hematopoietic cells through the TLR3-IRF3 pathway is critical for
protection from EMCV-D-induced diabetes.

Dendritic cells are necessary for protection from EMCV-D-induced diabetes
We finally investigated which hematopoietic cell types are implicated in the TLR3mediated control of EMCV-D-induced diabetes. We had previously observed the
accumulation of myeloid cells around the islets of WT mice after EMCV-D infection (see
Fig. 5). Interestingly, these cells expressed TLR3 (Fig. 7A), suggesting that they may be
responsible for the early type I IFN secretion that protects β-cells from EMCV-D. We
asked whether protective myeloid cells are macrophages or DC. To directly assess the
involvement of macrophages in preventing virus-induced diabetes, we infected WT mice
with EMCV-D after the injection of clodronate-containing liposomes, which deplete
macrophages(Van Rooijen 1989). Macrophage depletion increased susceptibility to
EMCV-D infection as reflected by survival, but had no effect on diabetes induction in
WT mice, suggesting that macrophages were dispensable for the protection of β-cells
(Fig. 7B,C). To assess the involvement of DC in preventing virus-induced diabetes, we
infected with EMCV-D CD11c-diphtheria toxin receptor (CD11c-DTR) transgenic mice,
which can be depleted of DC by injection of diphtheria toxin. DC-depleted mice were
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not only highly susceptible to EMCV-D infection, but also developed diabetes,
suggesting that DCs are critical for protection of β-cells from EMCV-D (Fig. 7D,E).
Because DC activate cytotoxic lymphocytes such as NK cells and CD8 T cells through
secretion of type I IFN, inflammatory cytokines and through cell-cell interaction, we
asked whether cytotoxic cellular responses contribute to EMCV-D clearance and
protection from diabetes. However, antibody-mediated depletion of NK cells or CD8 T
cells had no effect on the development of diabetes or survival of EMCV-D infection in
WT mice (data not shown). We conclude that DC-mediated protection of β-cells from
EMCV-D is independent of priming and/or activation of cytotoxic lymphocytes.
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Discussion
It is common knowledge that both RLR and TLR3 mediate responses to dsRNA and,
possibly, RNA viruses. However, while RLR have been convincingly shown to be major
players in innate responses to viruses in vivo, the literature is still contradictory as to the
in vivo role of TLR3. Initial studies did not detect any role of TLR3 in anti-viral innate
defense to EMCV (Kato, Takeuchi et al. 2006). However, more recent studies have
revealed that TLR3 does in fact contribute to EMCV anti-viral responses (Hardarson,
Baker et al. 2007). In this work we have demonstrated that both MDA5 and TLR3
provide protection from EMCV-D infection, but their contributions are different in
different tissues. In the heart, MDA5 plays the major role in determining resistance, in
the endocrine pancreas TLR3 is more prominent, in the exocrine pancreas MDA5 and
TLR3 are both important. Moreover, our bone marrow chimera studies demonstrated that
MDA5 and TLR3 act predominantly in stromal and hematopoietic compartments,
respectively. Thus, the differential roles of MDA5 and TLR3 are related to the distinct
cellular distribution of these sensors, as well as the tissue tropism of the viruses.

The type I IFN response to RNA viruses in vivo has been mainly attributed to RLRs. In
this study we confirmed that MDA5 induces the bulk of type I IFN production in
response to EMCV-D infection. However, using a sensitive bioassay for type I IFN, we
found that TLR3-mediated type I IFN is small but rapid. Thus, MDA5 and TLR3 induce
type I IFN responses with different magnitude and kinetics. The reduced magnitude of
type I IFN responses in the MDA5-/- mice explains the major survival defect, while
TLR3-/- mice show a comparatively mild defect. On the other hand, the delayed kinetics
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of the type I IFN response in TLR3-/- mice is responsible for the lack of viral control in
endocrine pancreas and diabetes, highlighting the importance of this early response.
Another study recently demonstrated that TLR2 is critical for early IFN production in
response to several DNA viruses(Barbalat, Lau et al. 2009).

In that study, TLR2

expression in inflammatory monocytes was particularly critical for the response. In
EMCV infection, dendritic cells were critical for early protection from diabetes. There
are several known subsets of CD11c+ DCs which could play a role and it remains to be
seen precisely which subset is responsible for this phenotype.

Because CD11c is

expressed on a variety of cells of the myeloid lineage, we also cannot completely exclude
a contribution from monocytes and inflammatory macrophages. Together, these results
suggest that early TLR-mediated production of IFN by myeloid cells is an important
component of the anti-viral response.

Because of different cellular distributions as well as extent and timing of anti-viral
responses, dsRNA sensors have different impact in distinct organs. This was seen in our
study contrasting the anti-viral response seen in the heart and the pancreas between the
MDA5-/- and TLR3-/- animals. This is a novel and important finding, which prompts the
investigation of viral sensors in individual organs and cell types during in vivo infections.
It is likely that anti-viral response in each organ relies on different dsRNA sensors and is
highly dependent on the tropism of the virus. Moreover, dsRNA and other TLR/RLR
ligands are being increasingly used as adjuvants in vaccines with the idea that stimulation
of the innate immune response will lead to increased and specific adaptive immune
responses. However, this work has revealed that the timing and level of expression of the
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sensors for these adjuvants varies during the antiviral response. It is important that we
understand the role of both the TLR and RLR systems in the immune response in
different organs and cell types to best take advantage of this strategy. It may be possible
to target these adjuvants to specific cells to maximize the desired immune response and
minimize harmful effects of cytokine production.

Although we did not observe the development of autoimmune diabetes after EMCV-D
infection, our finding that MDA5-/- mice were resistant to EMCV-D-induced diabetes is
intriguing. Recent association studies have implicated the MDA5-encoding gene Ifih1 in
susceptibility to human type I diabetes. In those studies, rare human Ifih1 alleles which
were shown to be defective for IFN production were seen to be protective, resulting in
failure of individuals with these alleles to develop T1D(Nejentsev, Walker et al. 2009).
Similarly, our results indicate that mice lacking MDA5 appear to be protected from
diabetes after EMCV-D infection, even in the presence of detectable EMCV-D in the
pancreatic islets. It is possible that the diabetes phenotype in MDA5-/- mice is not seen as
a result of the severe myocarditis the develops in these animals, however, the presence of
hyperglycemia in IRF3-/- and IFNβ-/- animals, which have similar survival phenotypes
and also develop myocarditis suggests that deficiency of MDA5 may be generally
protective within pancreatic islets. This may be due to the detrimental effects of IFN on
β-cell survival or an IFN-independent effect of MDA5 on cell survival, which has
recently been reported in studies of melanoma(Besch, Poeck et al. 2009; Tormo,
Checinska et al. 2009).
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Despite strong clinical correlation between viruses and diabetes as well as several
experimental models in which virus infection results in diabetes, the underlying
mechanism of how the human disease is initiated and whether viruses are directly
involved remains unclear. A recent report suggested that human diabetes can be initiated
by different mechanisms(Dotta, Censini et al. 2007). This study examined pancreatic
tissue of recent onset diabetic patients and reported two distinct histological patterns.
Half of the patients were noted to have T cell infiltrates within the islets, similar to the
autoimmune NOD mouse model. However, islets from other patients displayed
coxsackievirus B4 antigen and contained NK and myeloid cell infiltrates, but no T cells.
This suggests that type I diabetes may be initiated by either an autoimmune mechanism
or by direct virus infection. Likewise, some studies of EMCV-D-induced diabetes have
suggested that virus infection initiated an autoimmune T cell response, however, other
studies have reported no T cell infiltrate in the islets. Our results indicate that EMCVinduced diabetes in TLR3-/- mice does not involve autoimmune T cells, instead diabetes
results from direct viral infection of β-cells. However, this study tested mice on the
C57Bl/6 background, which are resistant to autoimmunity, and it is possible that studies
of EMCV on a genetic background susceptible to autoimmunity would have a different
outcome.

It is possible that polymorphisms in dsRNA sensors play a role in both

autoimmune and virus-induced diabetes.

MDA5 polymorphisms have clearly been

implicated in diabetes. In addition, a recent study has implicated non-functional TLR3
alleles with human myocarditis(Gorbea, Makar et al.), suggesting that inability to control
virus infection can lead to human disease. In this context, polymorphisms leading to
excessive IFN production by MDA5 may lead to autoimmune diabetes while non-
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functional alleles provide protection. In contrast, nonfunctional TLR3 alleles may lead to
increased susceptibility to viral infection and virus-induced diabetes.

Further

investigation is needed to determine how these sensors function to both limit infection
and trigger autoimmunity.
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Experimental Procedures
Mice and infections: MDA5-/-(Gitlin, Barchet et al. 2006), TLR3-/-(Alexopoulou, Holt
et al. 2001), DKO(McCartney, Vermi et al. 2009), CD11c-DTR(Jung, Unutmaz et al.
2002), IRF3-/-(Sato, Suemori et al. 2000), and IFNβ-/- (Takaoka, Mitani et al. 2000)mice
have been described previously.

All mice have been backcrossed to the C57Bl/6

background. Age-matched control mice were purchased from Jackson ImmunoResearch
Laboratories, Inc.

All mice used in these experiments were male.

EMCV-D was

obtained from Dr. John Corbett and was passaged in L929 cells. Infections were done at
1000 PFU per mouse by intraperitoneal injection.

BM chimeras: Recipient mice were γ irradiated with 1000 rad. After an overnight rest,
mice were reconstituted with 5 x 106 BM cells per mouse that had been harvested from
the femurs and tibias of age-matched donors. After 6 weeks, chimeras were used for
infections.

Virus titers: Organs from infected animals were frozen at -80°C immediately after
harvest. Subsequently, organs were suspended in 1ml DMEM and homogenized by bead
beating with 1.0mm beads (BioSpec Products, Inc). Organ homogenates were diluted
1:10 in DMEM and tested for viral titers in a plaque assay. L929 cells were seeded in 6
well plates and infected with 10-fold dilutions of tissue homogenate in duplicate. After 1
hour incubation, the inoculum was removed and wells were overlaid with complete
DMEM media containing 1.5% Seaplague agarose (Cambridge Biosciences). After 48
hours, a second overlay was added containing 1.5% SeaKem agarose (Cambridge
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Biosciences) and 0.01% neutral red (Sigma)in complete DMEM media. After 8 hours,
plagues were then visualized.

Blood/Serum measurements: Blood was taken at various time-points after infection
and centrifuged in serum separator tubes (Becton, Dickinson, and Co.) to isolate serum,
which was kept at -80 until use. Serum levels of troponin (Life Diagnostics, Inc) were
determined by ELISA.

Blood glucose was measured by Ascencia Elite glucometer

(Fisher) and care was taken to measure glucose levels at a consistent time of the day to
minimize variation. Serum levels of inflammatory cytokines were measured by Bioplex
assay using the mouse-23plex kit (Bio-rad) on a Luminex machine.

IFN bioassay: IFN levels in the serum were determined by bioassay (Newby, Pekosz J
Virol 2007). Briefly, L929 cells were incubated for 24 hours with standards or samples,
then infected for 10 hours with VSV-GFP. Cells were fixed and the percent of GFP+
cells were used to calculate IFN levels in the linear range of the standard curve. This
method was found to give similar results to IFNα ELISA (PBL), but was more sensitive
for low IFN values.

Liposome preparation and application: Multilamellar liposomes containing clodronic
acid disodium salt (Cl2MDP) (Sigma) in PBS or control liposomes without clodronate
were prepared as described by van Rooijen(Van Rooijen 1989; Calderon, Suri et al.
2006). Briefly, 86mg of phosphatidyl choline (Sigma) and 8 mg of cholesterol (Sigma)
were dissolved in 10 ml of chloroform and dried in an evaporator to form a lipid film.
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The lipid was dispersed in 10 ml of PBS for control liposomes or 10 ml of Cl2MDP
solution (2.5g into 10ml DI water, adjusted to pH 7.3) for clodronate liposomes. The
preparations were kept for 2 hours at room temperature, sonicated for 3 minutes, and
incubated overnight at 4ºC. Liposomes were then purified and washed by centrifugation
and resuspended in 4 ml of sterile PBS. A volume of 0.1 ml of liposome suspension for
every 10 g of body weight was injected i.v. for 5 consecutive days starting 48 hours
before EMCV infection.

Histology: Organs were harvested at indicated time-points after infection and tissue
sections prepared by either formalin-fixation paraffin-embedding or frozen in OCT
reagent. For EMCVpol, iba-2, activate caspase-3, synaptophysin, and H&E staining,
sections were deparaffinized, rehydrated, and stained with primary antibody at 1:1000
and then secondary ab at 1:2000. For TLR3 staining, frozen sections were stained with
primary antibody at 1:500 and secondary antibody at 1:2000.
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Figure Legends
Figure 3.1: Both MDA5 and TLR3 protect from EMCV-D infection.
WT, MDA5-/-, TLR3-/-, and DKO mice were infected with 1000 PFU EMCV-D i.p. and
monitored for survival (n=20). WT mice survived infection, MDA5-/- mice died at
average day 5, TLR3-/- died at average day 20, and DKO mice died at average day 2.

Figure 3.2: MDA5 is critical for protection in the heart.
WT, MDA5-/-, TLR3-/-, and DKO mice were infected with 1000 PFU EMCV-D i.p.
Serum and heart tissue were harvested at days 2, 4, and 7 from surviving mice and were
evaluated for troponin by ELISA (n>5) (A) and virus titer by plaque assay (n>6 for each
time point) (B). Statistical significance was calculated by two-tailed student’s t-test or
Mann-Whitney test for non-Gaussian data and is indicated by *= p<0.05, **= p<0.01,
***= p<0.001.

Figure 3.3: Both MDA5 and TLR3 control infection in the pancreas.
WT and KO mice were infected with EMCV-D as above. Serum samples were evaluated
for blood glucose (n>8) (A) or amylase and lipase (n>4) (B) at the indicated times postinfection. Pancreas was harvested at the indicated times and viral titers were determined
by plaque assay (C) (n>6). Statistical significance was calculated by two-tailed student’s
t-test and is indicated by *= p<0.05, **= p<0.01, ***= p<0.001.

Figure 3.4: Differential roles of MDA5 and TLR3 in the pancreas.
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Pancreas tissue samples from WT or knockout mice were harvested at day 2 or 4 as
indicated, fixed in formalin, and paraffin embedded. Tissue sections were stained using
anti-EMCVpol (A) or anti-iba-2 (B) by immunohistochemistry (n>3). Alternatively,
sections were stained for anti-iba-2 (brown) and co-stained with synaptophysin (blue) (Ca); anti-EMCVpol (brown) and synaptophysis (red) (C-b); anti-EMCVpol (brown) and
anti-iba-2 (red) (C-c); or active caspase-3 (brown) and synaptophysin (blue) (C-d).

Figure 3.5: MDA5 is critical in stroma, TLR3 in hematopoietic cells for control of
EMCV infection.
Bone marrow chimeras were developed between WT and MDA5-/- and WT and TLR3-/animals. Chimeras were infected with 1000PFU EMCV-D and evaluated for survival
(n>10) (A) and blood glucose (n>10) (B). Statistical significance was calculated by twotailed student’s t-test and is indicated by *= p<0.05, **= p<0.01, ***= p<0.001.

Figure 3.6: MDA5 and TLR3 control kinetically distinct IFN responses.
Serum samples from WT, MDA5-/-, TLR3-/-, and DKO mice were harvested at various
time-points after EMCV-D infection and evaluated for type I IFN production by bioassay
(n>5 per time point) (A). IRF3-/- and IFNb-/- mice were infected with EMCV-D and
monitored for survival (n=6) (B) and blood glucose (C). IRF3-/- and IFNb-/- chimeras
were infected with EMCV-D and monitored for survival (n=6) (D) and blood glucose
(n=6) (E). Statistical significance was calculated by two-tailed student’s t-test and is
indicated by *= p<0.05, **= p<0.01, ***= p<0.001.
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Figure 3.7: CD11c+ cells required for protection from EMCV-D-diabetes.
WT mice were treated with clodronate or PBS-containing liposomes and monitored for
survival (n=8) (A) and blood glucose (n=8) (B) after EMCV-D infection. CD11c-DTR
mice were treated with PBS or DT then monitored for survival (n=6)

(C) and blood

glucose (n=6) (D) after EMCV-D infection. To visualize TLR3+ cell infiltrates in the
islets, tissue sections were made from formalin-fixed paraffin-embedded WT pancreas 12
hours after EMCV infection. These sections were stained with anti-TLR3 (brown) and
synaptophysin (blue) (E). Statistical significance was calculated by two-tailed student’s
t-test and is indicated by *= p<0.05.

Supplementary Figure Legends
Supplementary figure 3.1. Extensive viral replication and pathology in MDA5-/hearts.
Heart tissue samples from WT or knockout mice were harvested at day 2, 4, or 7 as
indicated, fixed in formalin, and paraffin embedded. Tissue sections were stained by
H&E and evaluated for pathology (A) or stained for EMCVpol by immunohistochemistry
(B).

Supplementary figure 3.2.

Pathological damage of EMCV-D infection in the

pancreas.
Pancreas tissue samples from WT or knockout mice were harvested at day 2, 4, or 7 as
indicated, fixed in formalin, and paraffin embedded. Tissue sections were stained by
H&E and evaluated for pathology
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Abstract
The double stranded (ds) RNA analogue poly(I:C) is a promising adjuvant for cancer
vaccines because it activates both dendritic cells (DC) and natural killer (NK) cells,
concurrently promoting adaptive and innate anti-cancer responses. Poly(I:C) acts through
two dsRNA sensors, Toll-like receptor 3 (TLR3) and melanoma differentiationassociated protein-5 (MDA5). Here we investigated the relative contributions of MDA5
and TLR3 to poly(I:C)-mediated NK cell activation using MDA5-/-, TLR3-/- and MDA5-/TLR3-/- mice. MDA5 was crucial for NK cell activation, whereas TLR3 had a minor
impact most evident in the absence of MDA5. MDA5 and TLR3 activated NK cells
indirectly through accessory cells and induced distinct stimulatory cytokines, IFN-α and
IL-12 respectively. To identify the relevant accessory cells in vivo, we generated bone
marrow chimeras between either wild type and MDA5-/- or wild type and TLR3-/- mice.
Interestingly, multiple accessory cells were implicated, with MDA5 acting primarily in
stromal cells and TLR3 predominantly in hematopoietic cells. Futhermore, poly(I:C)mediated NK cell activation was not notably impaired in mice lacking CD8α DCs,
providing further evidence that poly(I:C) acts through diverse accessory cells rather than
solely through DC. These results demonstrate distinct, yet complementary roles for
MDA5 and TLR3 in poly(I:C)-mediated NK cell activation.
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Introduction
Microbial components play a major role in activating innate and adaptive immune
responses by triggering pattern recognition receptors (Ishii et al., 2008). Poly(I:C) is an
analog of viral double-stranded (ds) RNA that activates various immune cell types
through two major dsRNA sensors, melanoma differentiation-associated protein-5
(MDA5) and Toll-like receptor (TLR) 3. MDA5 is a cytosolic sensor, which detects
poly(I:C) that penetrates into the cytosol through yet undefined mechanisms (Ishii et al.,
2008). TLR3 is located in intracellular endosomes and detects poly(I:C) that has been
internalized by endocytosis (Matsumoto and Seya, 2008). Upon poly(I:C) detection,
MDA5 transmits signals through the adaptor IPS1, while TLR3 signals through the
adaptor TRIF (also known as TICAM1). Both these adaptors initiate downstream
signaling pathways that lead to activation of a similar array of transcription factors,
including IRF3, IRF7, IRF1 and NF-κB. These factors induce the expression of genes
encoding type I interferons (IFN), i.e. IFN-α and IFN-β, pro-inflammatory cytokines and
various molecules involved in antigen presentation (Kawai and Akira, 2008).

Poly(I:C) induces the maturation of dendritic cells (DC), boosting their ability to prime
and expand antigen-specific T cell responses (Kumar et al., 2008; Longhi et al., 2009;
Trumpfheller et al., 2008). Because of this DC stimulatory activity, poly(I:C) is a
promising adjuvant for vaccines, particularly for cancer vaccines that must overcome
both tolerance to tumor-associated self-antigens and the immunosuppressive influence of
the tumor microenvironment (Steinman and Banchereau, 2007). Poly(I:C) is also
extensively used to activate mouse NK cells in vivo. The NK cell stimulatory activity of
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poly(I:C) is potentially important for anti-cancer vaccines as it may contribute to tumor
eradication by inducing NK cell-mediated lysis of tumor cells. In humans, the NK cell
stimulatory activity of poly(I:C) has been chiefly attributed to its ability to trigger TLR3
expressed in cultured NK cells (Hart et al., 2005; Lauzon et al., 2006; Schmidt et al.,
2004; Sivori et al., 2004). Whether poly(I:C) also activates human NK cells through DC
or other accessory cells has not been investigated. In mice, poly(I:C) is thought to
activate NK cells primarily through DC. An initial study showed that poly(I:C) stimulates
TLR3 in DC, which consequently acquire the ability to activate NK cells (Akazawa et al.,
2007). A very recent study showed that poly(I:C) triggers both the TRIF and IPS-1
signaling pathways in CD8α DCs, which in turn activate NK cells in vitro (Miyake et al.,
2009). These results suggest that TLR3 and MDA5 may stimulate murine NK cells
indirectly through activation of DCs, particularly CD8α DCs.

In this report we investigated the relative contributions of MDA5 and TLR3 in poly(I:C)mediated activation of NK cells using MDA5-/-, TLR3-/- and MDA5/TLR3-/- mice. We
found that MDA5 has a predominant role in NK cell activation, whereas the contribution
of TLR3 is secondary and is most evident in the absence of MDA5. Both MDA5 and
TLR3 activated NK cell indirectly through accessory cells, but induced different NK cell
stimulatory cytokines, as MDA5 was essential for IFN-α and IFN-β whereas TLR3 was
required for interleukin (IL)-12 and, in part, for IFN-β. By generating bone marrow
chimeras between wild type (WT) and dsRNA sensor-deficient mice, we found that
MDA5 promotes NK cell activation mainly through stromal accessory cells, whereas
TLR3 acts predominantly through bone marrow-derived accessory cells. To determine
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whether the hematopoietic accessory cells that activate NK cells are, indeed, CD8α DC,
we examined mice deficient for the basic leucine zipper transcription factor ATF-like 3
(BATF3), which have a selective developmental defect in CD8α DC (Hildner et al.,
2008). We found that poly(I:C)-mediated stimulation of NK cells was minimally affected
in these mice, indicating that poly(I:C) acts through multiple accessory cells, rather than
solely through CD8α DC. We conclude that MDA5 and TLR3 mediate substantially
distinct and yet complementary functions during poly-I:C-mediated activation of NK
cells.
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Results and discussion
MDA5 has a predominant role in NK cell response to poly(I:C) in vivo.
To investigate the relative contributions of MDA5 and TLR3 in poly(I:C)-mediated
activation of NK cells, we injected WT, MDA5-/-, TLR3-/-, and MDA5/TLR3-/- (double
knockout, DKO) mice with poly(I:C); after 24 hrs we isolated spleen NK cells and
measured cytotoxicity ex vivo. NK cells from untreated WT and sensor-deficient mice
were unable to kill targets, while NK cells from poly(I:C)-treated WT mice killed up to
50% of targets (Figure 1A). NK cells from MDA5-/- mice treated with poly(I:C) had a
significant defect in cytotoxicity as only 20% of target cells were killed at maximum
effector:target ratios. NK cells from TLR3-/- mice treated with poly(I:C) had a modest,
but not significant cytotoxicity defect. However, NK cells from DKO mice were unable
to lyse targets after poly(I:C) stimulation. These results suggest that MDA5 can largely
compensate for lack of TLR3, and that TLR3 contribution to NK activation is evident
only in the absence of MDA5.

Another measure of NK cell activation is CD69 upregulation. CD69 is a cell surface
molecule induced by IFN-α/β that promotes lymphocyte retention in lymphoid organs
(Shiow et al., 2006). Following injection of poly(I:C), CD69 upregulation was partially
impaired in NK cells from MDA5-/- mice in comparison to those from WT mice and
completely abrogated in NK cells from DKO mice (Figure 1B). There was no decrease
in CD69 expression in the TLR3-/- mice, further implying that the effect of poly(I:C) is
predominantly mediated by MDA5. To determine the contributions of MDA5 and TLR3
to NK cell production of IFN-γ in response to poly(I:C), we isolated splenocytes 3 hrs
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and 4 hrs after injecting WT and dsRNA sensor-deficient mice with poly(I:C), and
determined the intracellular content of IFN-γ in NK cells. NK cells isolated from both
MDA5-/- and TLR3-/- mice 3 hours after poly(I:C) injection produced less IFN-γ than WT
NK cells (Figure 1C). However, by 4 hours following poly(I:C) injection, TLR3-/- and
WT NK cells generated similar amounts IFN-γ, whereas MDA5-/- NK cells still produced
less IFN-γ than either the TLR3-/- or WT NK cells. DKO NK cells did not produce IFNγ at any time point assessed following poly(I:C) stimulation. Altogether, these results
indicate that MDA5 plays a more predominant role than TLR3 in stimulating NK
cytotoxicity, CD69 upregulation and IFN-γ production.

MDA5 activates NK cells through an NK cell-extrinsic pathway
Since MDA5 is ubiquitously expressed, poly(I:C) could directly activate mouse NK cells
through MDA5. However, MDA5 is also expressed in DCs, which play a crucial role in
activating NK cells (Andoniou et al., 2005; Andrews et al., 2003; Ferlazzo et al., 2002;
Fernandez et al., 1999; Gerosa et al., 2002; Lucas et al., 2007; Mortier et al., 2008). Thus,
poly(I:C) may activate mouse NK cells through DC or other accessory cells expressing
MDA5. To test whether MDA5-mediated activation of mouse NK cells occurs in an NKintrinsic or -extrinsic manner, we co-cultured combinations of bone marrow DCs
(BMDCs) and NK cells from WT or dsRNA sensor-deficient mice and measured
cytotoxicity, CD69 upregulation and IFN-γ production in response to poly(I:C).
Remarkably, the defect seen in NK cell activation in the MDA5-/- mice in vivo was
entirely recapitulated in the co-cultures of WT NK cells with MDA5-/- BMDCs. MDA5-/BMDCs stimulated with poly(I:C) promoted NK cytotoxicity, CD69 upregulation and
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IFN-γ secretion less effectively than did poly(I:C)-activated WT BMDCs, (Figure 2AC). Following exposure to poly(I:C), DKO BMDCs were almost entirely incapable of
inducing NK activation. TLR3-/- BMDCs pulsed with poly(I:C) induced less IFN-γ
production in NK cells than did similarly treated WT BMDCs, whereas NK cell
cytotoxicity and CD69 expression were slightly augmented. No significant differences in
NK cytotoxicity, CD69 expression and IFN-γ production were detected when NK cells
from WT or DKO mice were co-cultured with poly(I:C)-activated WT BMDCs (Figure
2D-F). Consistent with this result, purified NK cells exhibited only modest or no increase
in CD69 expression and IFNγ secretion when directly stimulated with pIC even when
pretreated with IFNα and/or IL-12 to induce MDA5 and TLR3 (Supplementary Figure
1). We conclude that poly(I:C)-induced NK activation through MDA5 and TLR3 occurs
extrinsic to the murine NK cell itself. Moreover, while MDA5 deficiency in BMDC
severely impaired cytotoxicity and CD69 expression, TLR3 deficiency had minor impact
on these functions. In fact, TLR3 deficiency caused a slight increase of cytotoxicity and
CD69 expression. These in vitro results further corroborate the concept that MDA5 plays
a predominant role in murine NK cell activation, while the contribution of TLR3 is
limited but quite evident in the complete abrogation of NK activation observed in the
DKO mice and cells.

MDA5 and TLR3 disparately promote the secretion of cytokines that stimulate NK
cells
A variety of cytokines have been shown to activate NK cells. IFN-α/β augments NK cell
lytic capacity and expression of CD69 (Gerosa et al., 2002; Gerosa et al., 2005; Swann et
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al., 2007); IFN-α/β, IL-12 and IL-18 stimulate NK cell production of IFN-γ (Andoniou et
al., 2005; Biron et al., 1999; Chaix et al., 2008; Ferlazzo and Munz, 2004; Nguyen et al.,
2002; Trinchieri, 1995); IL-15 and IL-2 promote NK cell survival, proliferation and
effector functions (Granucci et al., 2004; Koka et al., 2004; Lucas et al., 2007; Mortier et
al., 2008; Waldmann and Tagaya, 1999). Since stimulation of both MDA5 and TLR3
with poly(I:C) leads to the production of IFN-α/β as well as inflammatory cytokines in
DC and other cells (Kawai and Akira, 2008), we predicted that the defect in NK
activation in vivo would be associated with a defect in cytokine production in the absence
of these dsRNA sensors. We found that serum IFN-α was completely abolished in the
MDA5-/- and DKO mice 24 hours after poly(I:C) stimulation (Figure 3A). In contrast,
there was no defect in serum IFN-α in TLR3-/- mice compared to WT mice, consistent
with previous studies (Kato et al., 2006; Kumar et al., 2008; Miyake et al., 2009). MDA5/-

mice had WT levels of IL-12p40 in the serum, whereas serum IL-12p40 was completely

abolished in TLR3-/- and DKO serum 6 hours after poly(I:C) stimulation (Figure 3B).
Other cytokines potentially relevant for NK cell activation, such as IFN-β, IL-18, IL-1β,
IL-15 or IL-12p70 were undetectable in the serum of all mice after poly(I:C) stimulation.

Similar to our findings in the serum, we found that poly(I:C)-stimulated MDA5-/- and
DKO BMDCs secreted less IFN-α than did WT BMDC (Figure 3C). TLR3-deficiency
did not diminish but, in fact, slightly augmented the IFN-α response. MDA5-/- BMDC
also failed to produce adequate amounts of IFN-β, although a very minor IFN-β response
was detectable early after poly(I:C) stimulation (Figure 3D). The IFN-β response was
partially reduced in TLR3-/- BMDCs and completely abolished in DKO BMDCs. Thus,
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MDA5 is essential for both IFN-α and IFN-β responses to poly(I:C), whereas TLR3 is
dispensable for IFN-α, although it contributes to IFN-β production. As opposed to type I
IFNs, MDA5-/- BMDCs secreted WT levels of IL-12p40, whereas TLR3-/- BMDCs
produced essentially no IL-12p40 (Figure 3E).

We conclude that MDA5 and TLR3 induce cytokines in response to poly(I:C) in different
ways. MDA-5 is required for the IFN-α and IFN-β response to poly(I:C), but not IL12p40. In contrast, TLR3 is required for IL-12p40 and, to a certain extent, IFN-β but is
not essential for IFN-α production. Consistent with previous studies in vivo (Longhi et
al., 2009), we found that poly(I:C)-induced NK cell activation in vitro was severely
impaired in the presence of an antibody that blocks the receptor for type I IFN (IFNAR)
(supplementary figure 2A, B). Moreover, co-cultures of NK cells and DC lacking IFNAR
showed that NK cell activation requires IFN-α signaling in both NK cells and DC
(supplementary figure 2C, D). Thus, type I IFNs are required for robust NK cell
activation; because MDA5-/- mice secrete very little IFN-α and IFN-β in response to
poly(I:C), the scarcity of these cytokines is probably responsible for the global defect in
NK cell activation in MDA5-/- mice following stimulation with poly(I:C). Although IL12 stimulates IFN-γ secretion (Trinchieri, 1995), the addition of an antibody neutralizing
IL-12 to co-cultures of NK cells and DC had minimal impact on poly(I:C)-induced NK
cell secretion of IFN-γ (supplementary figure 2A, B). Thus, the partial defect in IFN-γ
secretion observed in TLR3-/- mice may be due to insufficient IFN-β, perhaps combined
with the lack of IL-12 and/or other cytokines (Matikainen et al., 2001). Yet undefined
TLR3-induced cell-cell interactions might also contribute to NK cell secretion of IFN-γ.
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MDA5 and TLR3 function in different accessory cell populations
Our data indicate that MDA5 and TLR3 have distinct quantitative and qualitative impacts
on NK cell activation by poly(I:C). One potential explanation for this is differential
expression of MDA5 and TLR3 in cell types that have distinct capacities to produce
cytokines. To address this possibility we investigated the expression of MDA5 and
TLR3 in the spleen and liver before and after poly(I:C) stimulation by
immunohistochemistry. In naïve mice, MDA5 was broadly expressed in the red pulp and
the T-cell area of the spleen, and in the hepatocytes and interstitial cells of the liver
(Figure 4A). In contrast, TLR3 expression was more limited, including DC of the white
pulp, rare lymphoid cells in the marginal zone, red pulp macrophages as well as liver
interstitial cells, likely corresponding to Kupffer cells and endothelial lining cells (Figure
4B). Poly(I:C) stimulation induced a very strong increase in MDA5 expression in both
spleen and liver, with the only notable exception in the splenic B-cell area (Figure 4A).
Poly (I:C) stimulation also induced broader expression of TLR3 in the spleen,
particularly in the B-cell area, and in the liver, including the hepatocytes (Figure 4B).
These results suggested that MDA5 and TLR3 are constitutively expressed in partially
distinct cellular compartments of the spleen and liver, with MDA5 being more broadly
expressed than TLR3. Administration of poly(I:C) stimulates a stronger and broader
expression of both sensors, consistent with previous reports showing that type I IFNs
induce MDA5 (Ishii et al., 2008) and TLR3 expression (Matsumoto and Seya, 2008);
even under these conditions, however, the distribution of MDA5 and TLR3 do not
entirely overlap.
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To test the importance of MDA5 and TLR3 in the stromal versus hematopoietic
compartments, we created radiation chimeras between WT and MDA5-/- as well as WT
and TLR3-/- mice. Upon poly(I:C) stimulation, defective NK cell-mediated cytotoxicity
and reduced serum levels of IFN-α were seen in MDA5-/- chimeras that had received WT
bone marrow, while no cytotoxicity defect and minor impairment of systemic IFN-α
were observed in WT chimeras that had been grafted with MDA5-/- bone marrow (Figure
5A, B). Conversely, a slight decrease in cytotoxicity and marked reduction of systemic
IL-12p40 was evident in WT chimeras that had received TLR3-/- bone marrow showed,
while no obvious cytotoxicity or systemic IL-12p40 defects were observed in TLR3-//WT chimeras that were grafted with WT bone marrow (Figure 5A, C). These results
indicate that MDA5 activates NK cells by acting predominantly in the radio-resistant
stromal cell population, while TLR3 activates NK cells mainly through radio-sensitive
hematopoietic accessory cells.

Poly(I:C)-mediated NK cell activation in vivo occurs independently of CD8α DCs.
Since TLR3 is highly expressed in CD8α DC (Edwards et al., 2003) and CD8α DC
specialize in the secretion of IL-12 (Maldonado-Lopez et al., 1999), it seemed plausible
that the hematopoietic accessory cells involved in TLR3-induced NK cell activation
were, in fact, CD8α DC. This possibility was further supported by a recent study showing
that poly(IC) triggers the TRIF and IPS1 signaling pathways in CD8α DCs, inducing the
secretion of IL-12 and type I IFNs that activate NK cells in vitro (Miyake et al., 2009).
To directly test the contribution of CD8α DC to poly(I:C)-mediated NK cell activation in
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vivo, we analyzed Batf3-/- mice, which selectively lack the CD8α DC population (Hildner
et al., 2008). Following injection of poly(I:C), NK cells isolated from Batf3-/- killed
RMA-S cells only slightly less efficiently than WT NK cells (Figure 6A). Upregulation
of CD69, NK cell secretion of IFN-γ, serum IFN-α and serum IL-12p40 were similar in
Batf3-/- and WT mice (Figure 6B-E).

These results indicate that poly(I:C) triggers

secretion of NK cell stimulatory cytokines through multiple accessory cells rather than
solely through CD8α DC.
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Concluding remarks
In this study we provide the first demonstration that MDA5 is essential for robust
activation of murine NK cells in response to poly(I:C). While previously published
studies have suggested that poly(I:C) activates NK cells primarily through TLR3, our
data show that MDA5 is, in fact, more important than TLR3 for triggering all NK cell
functions, including cytotoxicity, CD69 and IFN-γ production. TLR3 has a minor impact
on NK cell activation and its role is most evident in DKO mice, where the lack of MDA5
and TLR3 completely abrogates the NK cell response to poly(I:C). This result also
excludes any contribution of other dsRNA sensors, such as RIG-I, to poly(I:C)-mediated
NK cell activation.

We demonstrated that MDA5- and TLR3-mediated NK cell activation is NK cellextrinsic. This conclusion is supported by in vitro experiments showing that lack of both
MDA5 and TLR3 in NK cells has no impact on the ability of poly(I:C) to induce NK cell
activation in the presence of WT DC, whereas deficiency of MDA5 and/or TLR3 in DC
impairs activation of WT NK cells. Similar results were recently obtained by Miyake et
al. (Miyake et al., 2009). Moreover, the extrinsic function of MDA5 was further
supported by in vivo experiments, showing that poly(I:C)-mediated NK cell activation is
normal in lethally irradiated WT mice reconstituted with MDA5-/- bone marrow cells,
which generate MDA5-/- NK cells. Although MDA5 is ubiquitously induced by type I
IFNs and therefore may be also expressed in NK cells, NK cells most likely lack efficient
mechanisms for poly(I:C) uptake, thereby preventing a direct effect of poly(I:C) on NK
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cells. It remains possible that the administration of poly(I:C) with liposomal reagents that
facilitate cytosolic entry of poly(I:C) may induce some direct activation of NK cells.

MDA5 and TLR3 contributed to poly(I:C)-induced NK cell activation by inducing
different NK cell stimulatory cytokines. MDA5 promoted IFN-α and IFN-β secretion,
whereas TLR3 was essential for IL-12p40 and, in part, for IFN-β production. Our in vitro
data indicates that type I IFNs are crucial for poly(I:C)-induced NK cell activation. These
data are consistent with the recent observation that NK cell secretion of IFN-γ in response
to poly(I:C) is blocked by injection of an anti-IFNAR antibody in vivo (Longhi et al.,
2009). The crucial role of type I IFNs in poly(I:C)-mediated NK cell activation, together
with the predominant function of MDA5 in inducing IFN-α and IFN-β secretion explain
the major defect in NK cell activation in MDA5-/- mice. Although IL-12 is a known
inducer of IFN-γ (Trinchieri, 1995), blockade of IL-12 did not affect poly (I:C)-induced
secretion of IFN-γ by NK cells, at least in vitro. Therefore, the transient defect in NK
cell secretion of IFN-γ observed in TLR3-/- mice may be due to insufficient IFN-β,
perhaps combined with a defect in IL-12 and/or other cytokines (Matikainen et al., 2001).
While our data underscore the roles of MDA5 and TLR3 in inducing IFN-α and IL-12,
MDA5 and TLR3 may also act by inducing cell surface molecules on accessory cells that
activate NK cells through cell-cell interactions or local delivery of cytokines. This is the
case for the α chain of the IL-15 receptor (IL-15Rα), which is induced by type I IFNs
and allows accessory cells to trans-present IL-15 to NK cells (Koka et al., 2004; Lucas et
al., 2007; Mortier et al., 2008). Accordingly, transcriptional analysis of WT, MDA5-/- and
TLR3-/- BMDCs stimulated in vitro with poly (I:C) showed that both MDA5 and TLR3
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are required for the induction of both IL-15Rα and its ligand IL-15 (supplemental figure
3). MDA5 and TLR3 may induce other cell surface molecules on accessory cells
involved in NK cell activation, either indirectly through type I IFN signaling, or directly
through IPS1 and TRIF and their downstream transcription factors IRF1/3/7 and NF-κB.

Our data indicates that the disparate impacts of MDA5 and TLR3 on poly(I:C)-induced
secretion of IFN-α, IFN-β and IL-12p40 and NK cell activation may be related, at least
in part, to the distinct cellular distribution of MDA5 and TLR3. Bone marrow chimera
experiments demonstrated that MDA5 mainly acts through stromal cells. The surfeit of
these cells and their general ability to produce type I IFNs can explain why MDA5
stimulation leads to a major release of IFN-α. MDA5 may have a more limited role in IL12 secretion because, although IFN-α induces IL-12p35 (Gautier et al., 2005; Hermann et
al., 1998), it also modulates IL-12 production from DC and monocytes/macrophages
(Nguyen et al., 2000). In contrast, TLR3 has a more restricted distribution and acts
mainly through hematopoietic cells. This may explain why TLR3 has a minor impact on
systemic IFN-α and a more prominent effect on IL-12 production. Although CD8α DC
express TLR3 (Edwards et al., 2003), specialize in the secretion of IL-12 (MaldonadoLopez et al., 1999), produce type I IFNs (Longhi et al., 2009) and strongly activate NK
cells in vitro in response to poly(I:C) (Miyake et al., 2009), our analysis of BATF3-/- mice
that lack CD8α DC demonstrates that poly(I:C)-mediated NK cell activation occurs even
in the absence of these cells, indicating that TLR3 acts through a variety of hematopoietic
accessory cells. Immunohistochemical analysis of TLR3 expression suggests that these
cells may include various DC and macrophage subsets in the white and the red pulp of
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the spleen as well as marginal zone B cells. In conclusion, our studies elucidate the
mechanisms by which poly(I:C) activates NK cells in vivo, demonstrating distinct, yet
complementary roles for MDA5 and TLR3 in stimulating NK cell effector functions
through a multiplicity of accessory cells.
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Materials and Methods
Mice, cell lines, and antibodies.

MDA5-/-, TLR3-/-, and IFNAR-/- mice have been

described previously (Alexopoulou et al., 2001; Trumpfheller et al., 2008). DKO mice
were made by intercrossing MDA5-/- and TLR3-/- mice.

These mice have been

backcrossed to the C57Bl/6 background. Age- and sex- matched C57BL/6 control mice
were purchased from the Jackson labs. Batf3-/- (Hildner et al., 2008) and WT (Taconic)
mice were on the 129SvEv background except for those used for IFN-γ staining, which
were backcrossed 6 times onto the C57BL/6 background. All mouse protocols were
approved by the Washington University Animal Care Committee. RMA-S cells were
maintained in RPMI 1640 supplemented with 10% FCS, penicillin/streptomycin, and
Glutamax. Blocking antibodies included anti-IFNAR (MAR1-5A3), anti-IL-12 (Tosh,
kindly provided by Emil R. Unanue) and anti-human IFNγR (GIR-208) as isotype
control.

Bone marrow chimeras. Recipient mice were γ irradiated with 1000 rad. After an
overnight rest, mice were reconstituted with 5 x 106 bone marrow cells per mouse that
had been harvested from the femurs and tibias of age- and sex- matched donors. After 6
weeks, chimeras were used for in vivo pIC stimulations.

Cell preparations. Single cell suspensions were prepared from spleens and depleted of
erythrocytes by ammonium chloride lysis. For NK purification, cell suspensions were
incubated with anti-DX5 coated MACS beads (Miltenyi) and purified by autoMACS.
Primary cells were cultured in complete media (RPMI 1640 (w/o) L-glutamine
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supplemented with 10% FCS, Sodium Pyruvate, Kanamycin sulfate, Glutamax, and nonessential amino acids). BMDCs were cultured in complete media with 2% GM-CSF for 7
days and then used in assays with complete media.

NK-DC co-cultures. For NK-DC cell co-culture experiments, 1x105 BMDCs were
cultured with 5 x104 NK cells in the presence or absence of 25µg poly(I:C) (invivogen).
In some experiments anti-IFNAR, anti-IL-12p70 or control antibody were added to the
cultures before the addition of the poly(I:C). In other experiments, purified NK cells
alone were stimulated with 0, 25, or 100µg poly(I:C) in the presence of 200, 1000, or
5000U IFNα (PBL); 1, 10, or 100ng/ml IL-12 (Peprotech); or 1ng/ml each IL-12 and IL18(Peprotech). After 24 hours, supernatants were harvested for cytokine detection and
NK cells were detached by washing with 1mM EDTA in PBS and analyzed by FACS.

Cytotoxicity Assays. To measure NK cytotoxicity ex vivo, splenocytes were prepared as
described above 24 hours after injecting mice with 100µg poly(I:C) i.v. and mixed with
1x105 Cr51-labeled RMA-S targets in decreasing E:T ratios. To measure NK cytotoxicity
in NK-DC co-cultures, Cr51-labeled RMA-S targets were directly added to the NK-DC
co-cultures. After 4 hours, supernatants were harvested and Cr51 release was measured in
individual samples as well as maximum and spontaneous release samples. Specific lysis
was calculated by (specific release) – (spontaneous release)/ (max release) –
(spontaneous release).
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FACS analysis. Splenocytes, cultured NK cells and BMDC prepared as described above
were treated with Fc block (HB-197) and stained with anti-CD3, anti-NK1.1, and antiCD69 (BD) for NK cells activation experiments or with anti-DX5 in place of NK1.1 for
Batf3-/- mice. Samples were processed on a FACSCalibur and analyzed with CellQuest
software (BD).

Ex vivo IFN-γ production. Mice were injected with 100µg poly(I:C) i.v. After 3 or 4
hours, splenocytes were prepared as described above and cultured with monensin for an
additional 3 or 4 hours. After incubation, cells were stained with anti-CD3 and antiNK1.1 or anti-DX5 (Batf3-/-) then fixed with PFA and permeabilized with saponin buffer
and stained with anti-IFN-γ. Samples were then analyzed by FACS as described above to
detect percentage of IFN-γ-producing NK cells.

Cytokine measurements. Serum samples were taken at 6 and 24 hours after injecting
mice with 100µg poly(I:C); supernatants of NK-DC cultures were harvested at 0, 6, 12,
and 24 hours after poly(I:C) stimulation. Type I IFNs and IL-12p40 were determined by
ELISA (PBL and eBioscience, respectively); IFN-γ was assessed by CBA (BD).

Statistics. Figures were plotted using Prism4 (GraphPad Software) indicating the mean
and standard deviation. Statistical significance was determined primarily by student’s t
test. ANOVA was used to determine significance for cytotoxicity assays. Significance is
indicated by * p<0.05, ** p<0.001, and *** p<0.0001.
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Immunohistochemistry. Spleen and liver sections were obtained from frozen (for antiTLR3 staining) and formalin-fixed paraffin-embedded tissue (for anti-MDA5 staining).
Primary antibodies included anti-MDA5 (rabbit polyclonal anti-mouse, AL180, Alexis,
Plymouth Meeting, PA, USA); anti-TLR3 (rat anti-mouse 11F8.1B7, kindly provided by
David M. Segal,

Experimental

Immunology

Branch,

NCI);

anti-B220

(Caltag

Laboratories) and anti-CD3 (rabbit monoclonal SP7, Thermo scientific). Anti-TLR3 and B220 were detected, after endogenous biotin blocking, using a rabbit anti-rat IgG (Mouse
Absorbed; Vector Laboratories, Burlingame, CA, USA). For anti-MDA5 and -CD3
stainings, sections were deparaffinized and subjected to antigen retrieval by incubating in
a water bath at 98°C for 40 minutes. Primary antibodies were detected using Envision
Rabbit (Dako, Glostrup). Reactions were revealed by DAB.

RNA preparation and RT-PCR. BMDCs were stimulated with 25µg poly(I:C) for 6 or
12 hours then RNA was harvested from the cells by RNeasy kit (invitrogen). cDNA was
synthesized from RNA (Superscipt RT kit, invitrogen) and relative levels of IL-15 and
IL-15Ra were determined by semi-quantitative PCR and normalized to GAPDH using the
following primers: IL-15-sense 5'-GCAGAGTTGGACGAAGAC-3' ; IL-15-antisense 5'AGCACGAGATGGATGTATT-3' ; IL-15Rα-sense 5'-TCTCCCCACAGTTCCAAAAT3'; IL15Rα-antisense 5'-GGCACCCAGGCTCAGTAAAA-3'; GAPDH-sense 5'GAGCCAAAAGGGTCATCATC-3'; GAPDH-antisense 5'CCATCCACAGTCTTCTGGGT-3'.
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Figure Legends
Figure 4.1. Poly(I:C)-induced NK cell activation is primarily mediated by MDA5.
WT, MDA5-/-, TLR3-/-, and DKO mice were injected with 100µg poly(I:C) i.v. After 24
hours, splenocytes were harvested and used as effector cells in a cytotoxicity assay with
labeled RMA-S targets (experiment performed using 1 mouse for each genotype in 4
independent trials) (A) or assayed for CD69 expression by FACS, gating on NK1.1+CD3splenocytes (experiment performed using 2 mice for each genotype in 3 independent
trials) (B). Alternatively, 3 or 4 hours after poly(I:C) injection, splenocytes were isolated,
cultured with monensin for an additional 3 or 4 hours, and analyzed for intracellular
content of IFNγ by FACS, gating on NK1.1+CD3- cells (experiment performed using 1
mouse for each genotype in 3 independent trials) (C). Statistical significance is indicated
by * p<0.05, ** p<0.001, and *** p<0.0001.

Figure 4.2.

MDA5 and TLR3 activate NK cells through NK cell-extrinsic

mechanisms. BMDCs from WT, MDA5-/-, TLR3-/-, and DKO mice were cultured with
purified NK cells from WT mice in the presence or absence of 25µg poly(I:C). After 24
hours NK1.1+CD3- cells were stained for CD69 expression (A) and IFNγ was measured
from culture supernatants (B) (experiments performed using BMDCs from 1 mouse for
each genotype and NK cells from 3 pooled mice in 4 independent trials). Alternatively,
Cr51-labeled RMAS targets were added to culture and cytotoxicity was measured (C)
(experiments performed using BMDCs from 1 mouse from each genotype and NK cells
from 3 pooled mice in 3 independent trials). In reverse experiments, BMDCs from WT
mice were cultured with purified NK cells from WT or DKO mice with or without
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poly(I:C). After 24 hours CD69 expression was determined by FACS (D) (experiments
performed using BMDCs from 1 mouse and NK cells from 3 pooled mice of each
genotype in 4 independent trials), IFNγ was measured in supernatants (E) (experiments
performed using BMDCs from 1 mouse and NK cells from 3 pooled mice of each
genotype in 4 independent trials), and cytotoxicity was measured against RMAS targets
(F) (experiments performed using BMDCs from 1 mouse and NK cells from 3 pooled
mice of each genotype in 3 independent trials). Statistical significance is indicated by *
p<0.05, ** p<0.001, and *** p<0.0001.

Figure 4.3. MDA5 and TLR3 mediate distinct cytokine responses.
WT, MDA5-/-, TLR3-/-, and DKO mice were injected with 100µg poly(I:C) i.v. Serum
was taken at 6 and 24 hours and assayed for IFN-α (experiment performed with serum
from 5 mice of each genotype in 1 independent ELISA assay) (A) or IL-12p40
(experiment performed with serum from 4 mice of each genotype in 1 independent
ELISA assay) (B) by ELISA. BMDCs from WT, MDA5-/-, TLR3-/-, and DKO mice were
stimulated with 25µg poly(I:C). At various time-points after stimulation, supernatants
were harvested and IFN-α (C), IFN-β (D), IL-12p40 (E) were measured by ELISA
(experiments performed with supernatants from BMDCs from each genotype in 4
independent experiments and evaluated by 2 independent ELISA assays). Statistical
significance is indicated by * p<0.05, ** p<0.001, and *** p<0.0001.

Figure 4.4. Expression patterns of MDA5 and TLR3 in spleen and liver.
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Frozen tissue sections from spleen and liver of unstimulated MDA5-/- and WT mice and
from poly(I:C)-injected WT mice were stained with anti-MDA5 (brown) and
counterstained with Hematoxylin (blue) (A). Formalin-fixed sections from spleen and
liver of unstimulated TLR3-/- and WT mice and poly(I:C)-injected WT mice were stained
with anti-TLR3 (brown) and counterstained with Hematoxylin (blue) (B) (experiments
performed using organs from 2 unstimulated and 4 pIC stimulated mice for each
genotype with staining done at least in duplicate for each). WP, white pulp; RP, red pulp.
Magnification = 200X, Scale bar = 100 microns. Expression of TLR3 in the B cell area of
the spleen was confirmed by staining with anti-B220 and anti-TLR3 (data not shown).

Figure 4.5. MDA5 and TLR3 act in different cellular compartments.
Bone marrow chimeras consisting of WT>MDA5-/-, MDA5-/->WT, WT>TLR3-/-, and
TLR3-/->WT mice were stimulated with 100µg poly(I:C) i.v. After 24 hours splenocytes
were harvested and used as effector cells in cytotoxicity assays against Cr51 labeled
RMAS targets (experiments performed using 1 mouse for each chimera in 3 independent
trials) (A). Additionally, serum was collected to measure systemic IFN-α (B) and IL12p40 (C) (experiments performed with serum from 4 mice of each chimera in 1
independent ELISA assay). Statistical significance is indicated by * p<0.05, ** p<0.001,
and *** p<0.0001.

Figure 4.6. Poly (I:C)-induced NK cell activation is independent of CD8α DCs.
WT and Batf3-/- mice were injected with 100µg poly(I:C) i.v.

After 24 hours,

splenocytes were harvested and used as effector cells in a cytotoxicity assay with labeled
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RMA-S targets (experiments performed using 1 mouse for each genotype in 3
independent trials) (A) or assayed for CD69 expression by FACS, gating on DX5+CD3splenocytes (experiments performed using 2 mice for each genotype in 2 independent
trials) (B). Alternatively, 3 hours after poly(I:C) injection, splenocytes were isolated and
cultured with monensin for 3 additional hours, at which time DX5+CD3- cells were
analyzed by FACS for intracellular IFN-γ content (experiments performed using 1 mouse
for each genotype in 3 independent trials) (C). Serum samples from poly(I:C) injected
mice were taken at 24 hours and IFN-α (D) and IL-12p40 (E) were measured by ELISA
(experiments performed with serum from 4 mice of each chimera in 1 independent
ELISA assay). Statistical significance is indicated by * p<0.05, ** p<0.001, and ***
p<0.0001.

Supplementary Figure Legends
Supplementary Figure 4.1. Limited effect of poly(I:C) on purified NK cells.
Purified NK cells from WT and DKO mice were cultured with increasing doses of pIC
along with IFNα or IL-12 alone or in combination. As a positive control, NK cells were
cultured with the combination of IL-12 and IL-18. After 24 hours, NK cells were
analyzed by FACS for CD69 expression (A-C) or IFN-γ was measured from culture
supernatants by CBA (D-F) (experiments performed using pooled NK cells from 5 mice
for each genotype in 3 independent trials).

Supplementary Figure 4.2. Type I IFN is essential for poly(I:C)-induced NK cell
activation through NK cell intrinsic and extrinsic mechanisms.
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(A, B) WT BMDCs were cultured with purified NK cells from WT mice in the presence
of poly(I:C) and anti-mouse IFNAR (MAR1), anti-mouse IL-12, or anti-human IFNGR
(GIR) as control. After 24 hours, NK cells were analyzed by FACS for CD69 expression
(A) or IFN-γ was measured in the co-culture supernatants (B) (experiments performed
using BMDCs from 1 mouse and NK cells from 3 pooled mice in 3 independent trials).
(C, D) Different combinations of WT and IFNAR-/- BMDCs and NK cells were cocultured with poly(I:C). After 24 hours, CD69 expression (C) and IFN-γ production (D)
were determined (experiments performed using BMDCs from 1 mouse for each genotype
and NK cells from 3 pooled mice in 3 independent trials). Statistical significance is
indicated by * p<0.05, ** p<0.001, and *** p<0.0001.

Supplementary Figure 4.3. MDA5 and TLR3 are required for poly (I:C)-induced
expression of IL-15Rα and IL-15.
BMDCs from WT, MDA5-/-, TLR3-/-, and DKO mice were stimulated with poly(IC) for 6
or 12 hours. RNA was harvested and levels of IL-15 and IL-15Rα were determined by
semi-quantitative PCR normalized to GAPDH (experiments performed using BMDCs
from 1 mouse for each genotype and in 4 independent trials). Statistical significance is
indicated by * p<0.05, ** p<0.001, and *** p<0.0001.
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Abstract
Organisms use a number of proteins to detect viral infection and activate the
antiviral response. The preceding chapters have provided evidence that two of these
proteins, the dsRNA sensors MDA5 and TLR3, have distinct functional roles in
activation of the innate immune system and control of viral infection. It is likely that the
role of these sensors, and other sensors of the innate immune system, are dependent on
several factors including viral tropism, cell and tissue specificity of PRRs, and
downstream signaling components. The combinations of these factors that occur during a
given viral infection are critical for successful control of that infection and determination
of the disease pathology. This chapter addresses how the results in the previous chapters
contribute to our understanding of how the RLR and TLR pathways work together to
coordinate control of infection. It also discusses potential mechanisms by which these
pathways may contribute to human disease and how we can apply this knowledge to
develop new therapeutic targets.
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Understanding the diversity between viral sensors
In this work we tested whether viral sensors of the TLR and RLR families serve
redundant or non-redundant functions. It has previously been appreciated that one way by
which viral sensors can be seen to have differential effects is by the recognition of
different ligands and thus different viruses, such as for Rig-I and MDA5. However,
several recent studies have demonstrated that both Rig-I and MDA5 function in a variety
of viral infections, suggesting that different sensors may also recognize different
components of the same virus, ensuring that multiple pathways are activated.
Additionally, different downstream signaling components could ensure that PRRs
activate the production of distinct cytokines. Finally, the differential expression of viral
sensors among tissues and cells types could contribute to their distinct roles in viral
infection. Results obtained in chapters 2, 3, and 4 help to highlight the importance of
these factors in the antiviral response.

PRR signaling results in distinct cytokine responses
Both RLRs and TLRs are able to initiate IFN and inflammatory cytokine
pathways in vitro. More recent studies, however, have revealed differential signaling by
RLRs and TLRs in individual cell types. One study found that influenza infection in
bronchial epithelial cells led to TLR3-dependent inflammatory cytokine induction and
Rig-I- dependent IFN response(1). Another recent study has demonstrated that human
keratinocytes contain functional TLR, RLR, and PKR signaling pathways and with the
use of siRNA and small molecule inhibitors they were able to show that TLR3 provides
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the main stimulus for NF-kB signaling, while RLRs are the primary initiators of IRF3
and IFN signaling in this cell type (2).
This work has also demonstrated that there is some specialization in cytokine
production that is dependent on whether the signal is transduced by MDA5 or TLR3. In
chapter 4, in response to pIC, MDA5 was found to be critical for robust type I IFN
production, while TLR3 was necessary for IL-12 production both in vivo and in vitro,
supporting previous findings. However, we also determined that there are important
kinetic differences in MDA5 and TLR3 cytokine production. Both in response to pIC in
vitro and viral infection in vivo, TLR3 was found to function at early time points for type
I IFN production. In contrast, MDA5 was shown to be important for robust IFN
production at late time points. There are several possibilities for why MDA5 and TLR3
are important for IFN production at different time points. The first is cellular location.
TLR3 is located in the endosomal compartment, while MDA5 is cytoplasmic. To detect
extracellular components, cells perform phagocytosis, which brings external contents into
endosomal compartments. This would allow initial contact with TLR3, with subsequent
internalization events from the endosomal to the cytoplasmic compartment being
necessary for contact with MDA5. Second, while TLR3 is constitutively expressed on
several cell types, MDA5 is an IFN-induced gene, and requires IFN production to be
upregulated. Therefore, early IFN production by TLR3 may serve to upregulate MDA5,
allowing for robust IFN production if the viral pathogen remains present, while
preventing needless systemic IFN responses if the TLR3 response is necessary to control
infection. In vivo another possibility for kinetic differences in MDA5 and TLR3 IFN
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production is distribution in different cell types, which will be discussed in the next
section.
The stimulation of different signaling pathways by TLRs and RLRs could have
important implications. Type I IFN and inflammatory cytokines promote distinct
immune responses. While IFN is known to activate a variety of immune cells, it also
promotes intracellular antiviral responses. In contrast, inflammatory cytokines typically
act to promote inflammation and the recruitment of immune cells without specific
antiviral activities. If we are able to distinguish which receptor is preferentially
responsible for the production of each cytokine, then we may be able to target activating
ligands to the endosomal or cytoplasmic compartments to activate MDA5 or TLR3
specifically to induce a particular cytokine response. It may also be possible to take
advantage of the kinetic difference in MDA5 and TLR3 signaling to initially target TLR3
in order to initiate a robust early IFN response, rather than targeting cells which have yet
to express MDA5. These techniques could be a tremendous advantage to the fields of
vaccine development as well as infectious diseases and tumor immunology since antiviral
sensors and their ability to induce cytokines are potential targets for therapy and
prevention. However, more work is needed to understand how individual and
combinations of cytokines act to control immune activation if we are to take advantage of
this knowledge.

Differential distribution of PRRs
The distribution of viral sensors in different cell and tissue types may be another
mechanism to differentiate their actions. This has been previously described in

149

comparison between conventional dendritic cells (cDC) and plasmacytoid DCs (pDC).
cDCs are specialized for pathogen detection and antigen presentation, while pDC
specialize in the secretion of type I IFNs in response to viruses (3, 4). In humans cDCs
express TLR1, 2, 3, 4, 5, 6 and 8, while pDCs preferentially express TLR7 and 9. CDCs
are capable of expressing high levels of RIG-I and MDA5, while pDCs also express these
cytoplasmic sensors, but, paradoxically, the sensors do not appear to function (5) unless
the pDCs themselves are infected(6). Although both cell types express different sensors,
they both respond to viruses and initiate an antiviral response.
Our data suggests that a similar mechanism exists between hematopoietic and
stromal tissues. In the response to both dsRNA and viral infection, we found that TLR3
functions in hematopoietic cells, while MDA5 functions in stromal tissues. Expression
patterns of the two sensors demonstrate that while MDA5 can be expressed on all cell
types after IFN stimulation, TLR3 is expressed on a more narrow range of cells primarily,
but not limited to, hematopoietic myeloid cells. It is likely that these different expression
patterns in vivo explain the functional differences between the two sensors. The presence
of TLR3 on hematopoietic cells suggests that these cells are important for initial
detection of viral infection. In this context TLR3 may be necessary to recognize dsRNA
from other cells that have been infected instead of by the infected cell itself. This is
supported by viral replication experiments in which MDA5, but not TLR3, is necessary
to limit viral replication of both MNV-1 (chapter 2) and EMCV (data not shown) in
infected dendritic cells in vitro. Production of early IFN by TLR3 may then lead to
induction of MDA5 on surrounding cells. This could lead to additional IFN production
as well as IFN-independent effects of MDA5, such as apoptosis, in infected cells that are
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necessary to control infection. However, this paradigm may not occur for all tissues, and
it is possible that different organs could have different expression patterns of PRRs.
The differential distribution of viral sensors may also be necessary to combat a
variety of different viral tropisms. Even within the picrona- and calici- virus families,
that is a broad distribution of viruses that infect different tissues as reviewed in chapter 1.
This likely explains the differential importance of MDA5 and TLR3 in control of their
infection. Infection of MDA5/TLR3 DKO mice with EMCV results in similar
susceptibility compared to mice lacking IFNAR, suggesting that these sensors are mostly
sufficient to control this infection. However, infection of MDA5-/- or DKO (data not
shown) mice with MNV-1 or CVB(7) results in a much less severe phenotype than
IFNAR-/- animals, suggesting that additional antiviral sensors are necessary to for
complete control of these infections. This could be related to the production of distinct
viral nucleic acid intermediates, but also could represent infection within different cell
types that are protected by different sensors. Thus, studying the expression patterns of
TLR and RLR family members in different organs and in response to different infection
may be necessary to understand their functional roles.

151

Implications for human diseases
T1DM
Viruses have long been implicated in T1DM. However, a direct causal role in
initiation of the disease has never been proven. Recent studies implicating MDA5, a
dsRNA sensor involved in detection of viral infection provided hope that such a
mechanism may be discovered. In chapter 3 we tested the importance of MDA5 in
prevention of virus-induced diabetes. Interestingly, mice lacking MDA5 did not develop
diabetes after EMCV-D infection, but rather developed myocarditis. However, mice
lacking TLR3 were highly susceptible to diabetes after EMCV infection, although TLR3
has not been implicated in diabetes in mice or humans. Is it possible to make sense of
this paradox? Results from human studies suggest a potential explanation. Work by
Dotta and others revealed two distinct histological patterns in recent onset diabetic
patients, one characterized by T cell infiltrate and the other by myeloid cell infiltrate. In
addition, viral antigens were detected in samples containing the myeloid infiltrate, but not
the T cell infiltrate, suggesting two potential mechanisms of T1DM- autoimmune and
viral. In this model MDA5 is implicated in autoimmune diabetes, while TLR3 may play
a role in diabetes initiated by viral infection.
Several studies have implicated MDA5 in autoimmune diabetes. Work by the
Todd group identified genetic polymorphisms that both increase and decrease
susceptibility to T1DM(8, 9). The mechanism by which these polymorphisms affect
T1DM susceptibility remain unclear, however, polymorphisms that result in defective
MDA5 IFN production appear to mediate resistance to T1DM. This is interesting
because of the known role for type I IFN in autoimmune diseases, and the myriad of
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effects type I IFN has on both β cells and the immune response in the islets. In contrast,
our results suggest that MDA5 does not play a role in virus-induced diabetes. This was
somewhat surprising because MDA5 is known to limit viral replication. One potential
explanation is that the severe myocarditis in these animals masked the diabetes
phenotype. Indeed, MDA5-/- animals were seen to have increased viral titers in the
pancreas as well as increased insulitis upon histological examination compared to WT
mice, suggesting that in the absence of myocarditis, diabetes would have developed. This
could be directly tested using mice lacking MDA5 only in the β-cells. More importantly,
this study did not address the role of MDA5 in autoimmune diabetes. The animals used
in this work were on the C57Bl/6 background, which do not develop spontaneous
autoimmunity. To properly evaluate the role of MDA5 in autoimmune T1DM, it is
necessary to have the mutation on the NOD background either by backcrossing or
making the knockout in newly created embryonic stem cells derived from NOD. These
mice could then be tested for development of diabetes to determine how a lack of MDA5
affects autoimmunity in these animals.
Data implicating TLR3 in autoimmune diabetes is less supportive than that of
MDA5. The primary association was seen using a model of diabetes in which a mouse
expressing a transgene for LCMV-GP developed autoimmune diabetes only after the
administration of pIC or virus(10). The authors suggested based on these results that
TLR3 was important for autoimmune diabetes, although this was never directly tested.
However, the existence of MDA5 was not known at that time, and it is likely that the
response to pIC was dependent on MDA5 and not TLR3 in these transgenic animals.
Moreover, mice lacking TLR3, which were backcrossed to the NOD background
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demonstrated no defect in the development of diabetes compared to WT NOD
animals(11). In humans, genome wide association studies have also provided no
evidence that human TLR3 polymorphisms are implicated in T1DM. Our data, however,
reveals a role for TLR3 in virus-induced diabetes. The pancreatic infiltrates seen in
TLR3-/- animals closely resemble “pattern B” infiltrates seen by Dotta(12). The question
remains, how prevalent is the autoimmune versus virus-induced diabetes? Clinically,
there appears to be no difference between pattern A and pattern B patients, the difference
was only detected histologically. In addition, this study included only 6 patients, and it is
unclear how representative this sample is to the population at large. Recent work from
nPOD (network of pancreatic organ donors) has begun to look at the pancreas of diabetic
patients on a more global scale. This project contains clinical as well as histological data,
so it is possible that there will be clinical correlations to the histological findings that can
be used to identify distinctions among T1DM patients. If this is indeed possible, it would
be interesting to know whether there are different genetic risk factors between the two
populations.

Myocarditis
Research into the mechanism of myocarditis has focused on whether the disease is
mediated primarily by viral infection or autoimmunity. Our results with EMCV infection
indicate that a virus-dependent mechanism occurs in this system. Increased viral titers in
MDA5-/- animals, and to a lesser extent, TLR3-/- animals correlated with increased
myocarditis as measured by histopathology and serum troponin levels. We were unable
to detect T cell infiltrates in the heart in these animals, however, we cannot rule out
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immunopathology mediated by innate cells in this system. It is known that the genetic
background influences the response to EMCV infection in mouse models. The mice we
used in this study, strain C57Bl/6, develop acute myocarditis in response to EMCV, and
it would be interesting to known the effect of MDA5 and TLR3 deficiency in mouse
strains which develop chronic myocarditis consistent with autoimmune etiology. It is
possible that on those backgrounds MDA5 and TLR3 may contribute to autoimmunity A
very recent human study has revealed that TLR3 polymorphisms are associated with viral
myocarditis and dilated cardiomyopathy(13). In this study susceptibility to myocarditis
correlated with TLR3 alleles demonstrating reduced downstream signaling capacity in
vitro. This suggests that select cases of human myocarditis correlate with failure to
control viral infection, similar to our findings in the mouse system, and may explain the
benefit of IFNβ therapy seen in clinical trials.

Gastroenteritis
In our study, we demonstrate that both MDA5 and TLR3 were necessary for
complete control of MNV infection. The absence of either sensor resulted in an increase
in viral titers, while deficiency of both sensors had a more profound defect (data not
shown). It is unclear whether human MDA5 and TLR3 polymorphisms result in
differential susceptibility to norovirus infection, but it is likely, based on the mouse data,
that inactivating mutations may lead to more severe norovirus infection. Recent findings
have demonstrated the importance of both innate immune genes and environmental
factors in the pathogenesis of inflammatory bowel disease. Genes involved in autophagy
as well as PRRs for bacterial ligands have been implicated in the disease process.
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Moreover, the presence of intestinal viruses such as MNV has been suggested to be
important for the full development of the disease phenotype in genetically susceptible
animals(14). In this model, genetic factors do not directly contribute to disease pathology
in the absence of an environmental stimulus, but when both environmental and genetic
factors are present, disease pathology results. It is possible that by regulating the level of
viral infection in the gastrointestinal tract, polymorphisms in MDA5 and TLR3 could
contribute to development of inflammatory bowel disease by altering the environmental
components of the disease. This remains to be investigated.

Implications for immune-targeted therapeutics
Stimulation with pIC activates both the MDA5 and TLR3 pathways, leading to
cytokine production and immune activation. We demonstrate that activation through the
two sensors has unique properties, which may be useful for the targeting of therapeutics.
Work by the Steinman group has shown that pIC is a very strong adjuvant that leads to
robust activation of a T cell response in the context of a tumor vaccine(15). However,
work from our lab has shown that pIC stimulation of MDA5 and TLR3 has distinct
effects on the T cell response. While TLR3 is necessary for a robust primary response,
MDA5 is critical for the memory T cell response(16). These results suggest that
targeting pIC to the correct hematopoietic or stromal compartment may help to ensure the
desired T cell response in the context of vaccination.
Cell-specific targeting of pIC may also be useful in cancer therapy. There has
been much effort towards the development of cancer vaccines that would activate the
immune response to attack tumor cells. To date, this strategy has been largely
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unsuccessful. There is hope that the use of pIC will boost the effectiveness of this
therapy. PIC has several beneficial effects on the immune response to tumors. It
activates NK cells, which can kill transformed cells; it activates antigen presenting cells,
priming the T cell response; and it activates T cells directly. By targeting pIC treatment
directly to specific immune cell types it may be possible to enhance the anti-tumor
immune response. In addition, pIC has a direct anti-tumor role in some cancers. Studies
of breast and liver cancers demonstrate that tumor cells that express TLR3 are susceptible
to apoptosis upon pIC treatment(17, 18). More recent evidence also implicates MDA5 in
susceptibility to pIC. Many melanomas upregulate MDA5 and are thus highly
susceptible to apoptosis upon delivery of pIC intracellularly. This effect was partially
dependent on MDA5-mediated IFN production, but partially independent of IFN(19, 20),
suggesting that MDA5 plays a direct role in apoptosis. Further studies are necessary to
determine whether MDA5 is upregulated in other types of cancers and if it can be
exploited. These exciting advances suggest that the ability of pIC to activate both antitumor immunity and direct tumor cytotoxicity make it a potentially useful therapeutic
agent.
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Conclusions
In this work we have shown that the dsRNA sensors MDA5 and TLR3 play
distinct roles in controlling viral infection. These sensors have unique cellular and tissue
expression profiles and stimulate production of distinct cytokine patterns when exposed
to their ligands. The ability of these sensors to recognize viral infection and initiate
production of interferon and inflammatory cytokines, both of which may play a role in
the development of autoimmunity, suggests that alteration of their activity could lead to
human disease. Indeed, polymorphisms in the genes encoding MDA5 and TLR3 have
been associated with T1DM, myocarditis, and encephalitis, and we are beginning to
understand the mechanisms by which these diseases develop. In addition to
understanding the underlying disease mechanisms caused by these genes, it may be
possible to use our understanding of tissue distribution and receptor-specific signaling
pathways to target these pathways for human therapeutics. Knowledge of MDA5 and
TLR3 function may lead to important advances in vaccines, autoimmunity, and cancer
therapy. We hope that this work will lead to further discoveries in these fields.
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